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ABSTRACT 
 
Ray K. Chihara 
 
STUDY OF PHYSIOLOGIC AND IMMUNOLOGIC INCOMPATIBILITIES OF PIG 
TO HUMAN TRANSPLANTATION  
 
Solid organ transplantation is limited by available donor allografts.  Pig to 
human transplantation, xenotransplantation, could potentially solve this problem 
if physiologic and immunologic incompatibilities are overcome.  Genetic 
modifications of pigs have proven valuable in the study of xenotransplantation by 
improving pig to human compatibility.  More genetic targets must be identified for 
clinical success.  First, this study examines platelet homeostasis incompatibilities 
leading to acute thrombocytopenia in liver xenotransplantation.  Mechanisms for 
xenogeneic thrombocytopenia were evaluated using liver macrophages, Kupffer 
cells, leading to identification of CD18, β2 integrin, as a potential target for 
modification.  When disruption of CD18 was accomplished, human platelet 
binding and clearance by pig Kupffer cells was inhibited.  Further, human and pig 
platelet surface carbohydrates were examined demonstrating significant 
differences in carbohydrates known to be involved with platelet homeostasis.  
Carbohydrate recognition domains of receptors responsible for platelet clearance 
Macrophage antigen complex-1 (CD11b/CD18) and Asialoglycoprotein receptor 
1 in pigs were found to be different from those in humans, further supporting the 
involvement of platelet surface carbohydrate differences in xenogeneic 
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thrombocytopenia.  Second, immunologic incompatibilities due to antibody 
recognition of antigens resulting in antibody-mediated rejection were studied.  
Identification of relevant targets was systematically approached through 
evaluation of a known xenoantigenic protein fibronectin from genetically modified 
pigs.  N-Glycolylneuraminic acid, a sialic acid not found in humans, was 
expressed on pig fibronectin and was identified as an antigenic epitope 
recognized by human IgG.  These studies have provided further insight into 
xenogeneic thrombocytopenia and antibody-mediated rejection, and have 
identified potential targets to improve pig to human transplant compatibility. 
 
 
Christopher Burlak, Ph.D., Chair 
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Chapter 1: Introduction 
 
Transplantation of solid organs has transformed medicine for end stage 
organ failure, yet shortage of donor allografts continues to limit the use of these 
lifesaving medical treatments.  The transplant waitlist has over 100,000 patients 
in the United States and grows each year while the number of patients 
transplanted has been relatively stagnant demonstrating a worsening shortage of 
donor organs despite high selectivity for enlistment (Figure 1-1).  
Xenotransplantation, transplant across species, has been proposed as a 
potential solution to the shortage of donor organs.  However, barriers to 
xenotransplantation must be overcome for successful clinical application.  Our 
research focuses on understanding the underlying mechanisms behind these 
barriers to identify and develop methods to overcome the interspecies 
incompatibilities faced in xenotransplantation.  
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History of Xenotransplantation 
The concept of xenotransplantation dates back thousands of years and is 
seen in multiple cultural and religious studies.  For example, the ancient 
Egyptians built the Great Sphinx of Giza around 2500BC (1), a statue with lion’s 
body with a human head.  The Lamassu a protective deity on the cover of the 
Xenotransplantation journal (2) was depicted by a winged lion or bull with a 
human head accredited most often to the ancient Assyrians.  Although many 
other recognizable mythical figures with combined features of several animal 
species exist such as the chimera and griffon, the first specific written description 
of xenotransplantation most likely comes from the story of Ganesha the god of 
wisdom who obtained the iconic elephant head through transplantation after 
decapitation by Shiva the god of destruction according to Hindu mythology and 
the Puranas, ancient Hindu texts, dated around 600BC (Figure 1.2) (3). 
The xeno- portion of word xenotransplantation comes from Greek origins 
meaning strange or foreign (4, 5), albeit the use of xenotransplantation in science 
is neither strange nor foreign.  Transplantation across species has been widely 
utilized experimentally to study immunology, graft rejection and cancer.  For 
example, injection of human cancer cells into NOD-scid IL2rγnull mice has greatly 
enhanced knowledge in cancer biology and treatment (6). 
The modern concept of clinical xenotransplantation generally refers to the 
transplant of living nonhuman biological material into humans for treatment of 
disease.  Decellularized animal products such as biological mesh for abdominal 
wall hernias, skin grafts and cardiac valves for aortic stenosis are usually not 
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included in the clinical definition for xenotransplantation.  The field is further 
divided into several subcategories, which include living cell, tissue and solid 
organ transplantation.  Use of xenogeneic living cells and tissues are being 
explored for treatment of Parkinson’s disease (neurons), diabetes mellitus 
(pancreatic islets), anemia (red blood cells), burns (skin) and cataracts (cornea) 
(7).  Xenogeneic mesenchymal stem cells may provide a source of omnipotent 
cells for regenerative medicine.  Solid organ xenografts could be utilized as a 
treatment for end stage organ failure.  Potential xenotransplant related medical 
uses are summarized in Figure 1-3 (7). 
Xenografts are categorized into concordant or closely related and 
discordant or distantly related nonhuman organs.  Limited clinical successes 
have been obtained through concordant xenotransplantation of the liver, heart 
and kidney.  Dr. Starzl performed two liver xenotransplants in 1992-1993 using 
baboon grafts with patient survival of 70 and 26 days (8).  Dr. Bailey performed 
an orthotopic cardiac xenotransplant using a baboon graft on a female neonate, 
baby Fae, with hypoplastic left heart in 1984 resulting in a survival of 20 days (9).  
The most notable success was Dr. Reemtsma’s concordant xenotransplant 
studies in 1963-1964, an era prior to routine use of hemodialysis and the 
immunosuppressant cyclosporine, when several chimpanzee kidneys were 
transplanted into patients with survival up to 9 months (10).  Although concordant 
renal xenotransplant trials demonstrated great potential, the advent of 
hemodialysis, concerns of zoonosis, ethical dilemmas and impracticality for 
large-scale production prevented further use of nonhuman primate organs.  
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While hemodialysis has greatly impacted treatment of end stage renal disease, 
kidney transplantation is sought after because of advantages such as reduced 
mortality, reduced cardiac events and improved quality of life (11). 
Porcine organs, discordant xenografts, have been considered the most 
viable option, since pigs have relatively similar physiology, shorter gestation time, 
reproduce in liters of 5-12 and have decreased risks for zoonosis.  Pigs are also 
considered more ethically acceptable, since over 100 million pigs are sacrificed 
per year as a source of dietary protein and in several medical applications for 
example mesh for hernias, cardiac valves and medicines including heparin for 
anticoagulation and insulin for diabetes historically.  Although discordant 
xenograft trials in humans have resulted in failure mainly due to antibody-
mediated rejection with maximal survival of pig liver and cardiac xenotransplant 
patients at 26 and 23 hours respectively, organs transplanted were from 
domestic pigs (12, 13).  Genetically modified pig organs have not been attempted 
in humans due to governmental restrictions, but have shown promising results in 
pig-to-nonhuman primate xenotransplant models.  Whether or not genetically 
modified pig-to-human transplantation will yield successes similar or greater to 
historical concordant clinical xenotransplant trials is yet to be determined. 
  
 5 
Strategies for Improving Pig and Human Compatibility  
Recent xenotransplant studies have focused on organ and tissue rejection 
and physiologic incompatibilities resulting from cross-species transplantation in 
order to understand and bridge the compatibility gap between pigs and humans.  
Research in humoral immunity, accommodation, tolerance, coagulation and their 
relationship to physiologic incompatibilites and the organ rejection process has 
advanced through use of xenotransplant models (14-16).  Strategies utilized to 
improve compatibility can be categorized as changes to either the host or donor.  
Host modification strategies include porcine bone marrow transplantation for a 
chimeric recipient immune system (17, 18), porcine thymus transplantation (19), 
plasmapheresis and various immunosuppressive drugs.  Donor modifications 
include production of pig-human chimeras (20) and genetic modifications to pigs.  
Since immunosuppression, plasmapheresis, porcine bone marrow and thymus 
transplantation involve further procedures to the host increasing the likelihood of 
sequelae, donor modification would be preferred unless changes to the host are 
highly specific with minimal risks.  Ethical concerns with production of pig-human 
chimeras through use of human stem cell injections into fetal pigs and increased 
risks of zoonosis (20) have made genetic modification to pigs the most appealing 
method of improving pig-to-human compatibility. 
The ability to genetically alter pigs highlights a key difference between 
allo- and xenotransplantation.  In allotransplantation, bloodtype, crossmatch and 
human leukocyte antigen testing must be completed between an available donor 
and recipient to determine compatibility, whereas the donor may be directly 
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modified to become compatible with the recipient in xenotransplantation.  The 
product of porcine genetic modifications that overcome immunologic and 
physiologic barriers could be directly utilized clinically. 
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Genetic Engineering and Modifications 
Pigs have demonstrated good genetic engineering potential by successful 
transgenesis of several human genes and knockout of a pig gene using sperm-
mediated gene transfer, homologous recombination and cloning techniques (21-
23).  Pigs transgenic for human complement regulation, apoptosis, coagulation, 
inflammation and platelet activation genes have been generated (7, 24-31).  
Transgenic pigs expressing human complement regulatory proteins CD46, CD55 
and CD59 have demonstrated reduced incidence of hyperacute rejection (32-34).  
The knockout of α1,3-galactosyltransferase gene (GTKO) lead to substantial 
improvements in antibody-mediated rejection under clinically acceptable levels of 
immunosuppression (22).  Transgenesis of human anti-apoptosis, anti-
inflammatory and anti-coagulation genes require further investigation after 
combination with pigs of GTKO background in order to fully determine clinical 
significance in organ xenotransplantation. 
Major technological advancements in genetic engineering have come 
mainly from zinc finger nucleases, which are engineered DNA sequence-binding 
modules combined usually with a Fok1 non-specific DNA cleavage domain 
(Figure 1-4) (35-37).  Recently, zinc finger nucleases have demonstrated efficient 
and straightforward methods to alter the pig genome by successful generation of 
knockout pigs (38, 39).  The use of zinc finger nucleases to knock-in genes has 
been utilized in mice (40).  Targeted knock-in of a gene into a specific locus has 
the advantage of simultaneous knockout of an endogenous gene resulting in 
replacement rather than introduction of a gene.  Similarly, transcription activator-
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like effector nucleases (Talens) and meganucleases could be used to modify the 
porcine genome.  Further development of genetic modification techniques 
through use of zinc fingers nucleases, Talens and meganucleases would allow 
for quick and efficient modification of pigs.  The best combination of genetic 
modifications and other novel genetic targets must be identified to utilize recent 
advancements in genetic engineering. 
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Current Perspectives on Organ Specific Barriers to Xenotransplantation 
Since solid organs have varying function and structure, it is not surprising 
to find varying organ specific barriers to xenotransplantation.  The maximum 
survival time of pig organs vary from 5 days for lung, 8 days for liver, 57 days for 
orthotopic heart and 90 days for kidney in genetically modified pig-to-nonhuman 
primate xenotransplant models (7).  Coagulation dysfunction for lung and 
ensuing vasculature thrombosis (29, 41), thrombocytopenia for liver and resultant 
hemorrhage (42, 43) and antibody-mediated rejection for heart and kidney (44-
46) are the current major organ specific obstacles to clinically applicable 
xenotransplantation.  Coagulation dysfunction and thrombocytopenia issues for 
lung and liver respectively are thought as immediate physiologic barriers 
demonstrating substantially decreased xenograft survival compared to heart and 
kidney where non-immediate immunologic reasons are considered the primary 
barrier (Figure 1-5) (7). 
Among these organs, the liver stands out, because there are no clinically 
available options to temporarily sustain patients with acute liver failure as a 
bridge to allotransplantation.  Dialysis, left ventricular assist and extracorporeal 
membrane oxygenation exists for kidney, heart and lung respectively and has 
been successfully utilized as a bridge to allotransplantation (47, 48).  Bioartificial 
liver devices, currently undergoing clinical trials, and extracorporeal porcine liver 
perfusions would only work with select patients due to failure in dealing with 
portal hypertension commonly associated with acute on chronic liver failure.  The 
liver may also have immune compatibility advantages, since allotransplantation 
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studies have shown the liver to be resistant to hyperacute rejection which may be 
explained by a unique type of immune privilege known as liver tolerance (49).  If 
acute thrombocytopenia issue could be resolved, liver xenotransplantation may 
be utilized as a bridge to allotransplantation (42, 50). 
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Thrombocytopenia in Liver Xenotransplantation 
GTKO pig liver to nonhuman primate xenotransplant studies resulted in 
thrombocytopenia and bleeding within hours of reperfusion (42).  Since these 
studies did not demonstrate signs of rejection (51), xenogeneic 
thrombocytopenia is now considered the immediate barrier to clinically applicable 
liver xenotransplantation.  Two general hypotheses have been proposed and 
evaluated for the observed thrombocytopenia, which are platelet aggregation 
with circulating monocytes and neutrophils (52) and clearance by liver sinusoidal 
cells (Figure 1-6) (53).  Platelet clearance by the liver more readily explains the 
immediate loss of platelets seen in nonhuman primate models compared to 
platelet aggregation, although a combination of both maybe responsible for 
overall thrombocytopenia. Our studies with ex vivo porcine liver perfusion with 
human platelets demonstrated platelet phagocytosis by liver sinusoidal cells 
(Figure 1-7) (53).  Determination of mechanisms behind platelet phagocytosis 
would lead to genetic targets for attenuating thrombocytopenia. 
For insights into causes of xenogeneic platelet clearance, platelet 
homeostasis studies were examined leading to several potential mechanisms for 
exploration.  Transfusion medicine research demonstrated that platelets must be 
stored at room temperature to avoid rapid clearance from circulation seen when 
platelets stored under cold conditions are transfused (54, 55).  Asialoglycoprotein 
receptor 1 (ASGR1) expressed by hepatocytes and macrophage antigen 
complex 1 (Mac-1) were implicated in clearance of platelets that have lost sialic 
acid carbohydrates exposing beta glucans (Figure 1-8) (56-59). Porcine liver 
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sinusoidal endothelial cells (LSEC) were isolated and determined to express the 
ASGR1 receptor (60).  Porcine LSEC involvement with human platelet binding 
and phagocytosis was identified (53).  Inhibition and siRNA experiments revealed 
ASGR1 as a receptor involved with xenogeneic platelet clearance (60).  Porcine 
Kupffer cells (KC), liver macrophages, were found to express the Mac-1 receptor 
and were evaluated for human platelet phagocytosis in Chapter 2. 
Since thrombocytopenia was known to occur when platelets were exposed 
to cold and septic conditions, platelet differences were evaluated leading to 
discovery of platelet carbohydrate changes under specific conditions.  Platelets 
exposed to the cold have increased galactose β1-4 glucosamine (Gal β1-4 
GlcNac) carbohydrate expression (57, 61).  Thrombocytopenia caused by 
streptococcus pneumoniae sepsis was attributed to neuraminidase, an enzyme 
that cleaves off neuraminic / sialic acids a common terminal carbohydrate on 
oligosaccharides, released by bacteria resulting in neuraminic acid removal from 
platelets resulting in increased exposure of Gal β1-4 GlcNac (56).  Since ASGR1 
and Mac-1 have carbohydrate recognition domains with affinity towards Galβ1-4 
GlcNac, carbohydrate changes in platelets were implicated as a cause of platelet 
clearance.  To determine if the same principles applied to the xenogeneic 
thrombocytopenia, human and pig ASGR1, Mac-1 receptors and platelet 
carbohydrates were evaluated and compared in chapter 3. 
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Xenoantigens and Antibody-Mediated Rejection 
Antibody-mediated rejection is considered the primary barrier to heart and 
kidney xenotransplantation, although antibody-mediated rejection maybe a 
barrier for long-term liver xenografts once thrombocytopenia is overcome.  The 
transplant rejection process occurs when the host immune system identifies the 
donor graft as non-self. Rejection has been classically linked to host immune 
recognition methods of pathogens that continually invade our innate immune 
barriers, skin and oral mucosa.  Although the rejection process is not completely 
understood, GTKO pig-to-nonhuman primate xenotransplant models have shown 
antibodies recognizing antigens on xenografts as a major factor in graft rejection 
(19, 44-46, 63-66).   
The removal of the xenoantigen galactose α1-3 galactose carbohydrate 
(αGal) from pig glycoproteins through generation of GTKO pigs lead to greatly 
reduced incidence of hyperacute xenograft rejection demonstrating the 
importance of the humoral immune system in the rejection process.  Although 
removal of αGal resulted in decreased antibody binding, complement deposition 
and cell lysis, acute vascular antibody-mediated rejection remained for renal and 
cardiac GTKO pig-to-nonhuman primate studies from remaining xenoantigens 
(44-46, 67).  The proposed model for acute vascular antibody-mediated rejection 
begins with preformed and induced host antibodies that bind antigens on the 
xenograft endothelium initiating a cascade of events.  The antibodies cause 
complement activation and deposition resulting in activation and lysis of 
xenograft endothelial cells exposing basement membranes.  Activation of the 
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endothelium combined with exposed underlying extracellular matrix and collagen 
triggers the activation and degranulation of platelets, activation of the coagulation 
cascade and thrombosis of vasculature leading to downstream ischemia and 
eventual graft failure (Figure 1-9) (62, 68).  Antibody-dependent cell-mediated 
injury to the xenografts may also contribute to rejection through activation of NK 
cells by antibodies bound to xenograft endothelium resulting in the release of 
cytokines that promote endothelial cell activation and eventual apoptosis (69).  
GTKO pig-to-nonhuman primate xenotransplant models demonstrate the 
important role antibody recognition of xenoantigens play in xenograft rejection. 
Further modifications of donor antigenic epitopes and/or additional 
recipient treatment strategies appear necessary to prevent antibody-mediated 
rejection which led to generation of xenoantigen lists though proteomic studies 
requiring validation (44, 46, 70).  Increasing knowledge in the normal 
homeostatic role of naturally occurring auto-antibodies to endothelial cells, 
normal and altered intracellular, cell surface and plasma proteins (71-73) and 
relation to damage associated molecular patterns (74) calls into question whether 
or not mere existence of antibodies towards the xenogeneic version of proteins is 
enough to determine pathologic significance.  In addition preformed antibodies 
recognizing both autologous and xenogeneic forms of a protein may not share 
the same antigenic epitopes and consequently cannot be ruled out as 
pathologically irrelevant.  Another confounding problem is the use of denaturing 
agents in protein analysis.  The presence of preformed antibodies to misfolded or 
altered autologous proteins complicate immunogenic analyses of denatured 
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GTKO proteins due to possible exposure of normally hidden physiologic 
antigenic epitopes (Figure 1-10a) used probably for waste clearance (72).  This 
concept can be clearly illustrated through evaluation of preformed human 
antibodies to native-globular and denatured-reduced forms of purified human 
serum albumin.  The presence of preformed human IgG and IgM antibodies 
recognizing denatured-reduced and not the native-globular form of allogeneic 
albumin are demonstrated in (Figure 1-10b).  Nonetheless, denatured proteins 
are studied because of experimental difficulties associated with native proteins 
including solubility, interfering protein-protein interactions, protein separation and 
resolution.  While many of the above issues have been avoided through study of 
induced antibodies after pig-to-nonhuman primate xenotransplantation, this 
approach is limited because this strategy cannot be used to identify preformed 
antibodies recognizing xenoantigens (44, 45).  In addition, induced antibodies 
may develop secondary to cellular and tissue damage caused by the primary 
preformed antibody-mediated immune response resulting in exposure of 
intracellular proteins normally hidden from the endovascular compartment (75).  
Even after determination of an antigenic protein, many potential antigenic 
epitopes need to be considered on glycoproteins including peptides, 
glycosylations and glycosylated peptides.  Relevant antigenic non-glycosylated 
proteins may be humanized or knocked out if noncritical for survival, however the 
same may not hold true for glycoproteins because antigenic glycosylations may 
be added post-translationally to humanized protein peptide sequences.  
Therefore, understanding pathologic human antibody recognition of antigenic 
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epitopes on xenogeneic glycoproteins is key to discovery of relevant genetic 
targets for modification. 
A glycoprotein xenoantigen candidate for study is GTKO pig fibronectin 
because of relative abundance, ubiquitous expression in tissues, production by 
endothelial cells that line blood vessels and ability to induce antibodies in a 
xenotransplant model (44).  Studying human fibronectin in parallel with GTKO pig 
fibronectin has several advantages.  Since protein isolation and storage 
conditions may lead to denaturation and exposure of physiologic antigenic 
epitopes (76), evaluation of the human form of fibronectin as a control would 
alleviate xenoantigen analysis problems associated with conformation and 
protein degradation dependent antibody recognition.  Additionally, various useful 
glycoprotein purification methods used have the potential to generate protein 
misfolding and therefore, must be compared back to the autologous human 
fibronectin treatment to discern differences between pathologic and physiologic 
antibody recognition.  Simultaneous comparison of the GTKO pig and human 
fibronectin and endothelial cells address many challenges associated with 
identification of pathological antigenic epitopes, which are described in chapter 4. 
The Hanganutziu-Deichter (HD) antigen, N-glycolylneuraminic acid 
(Neu5Gc) containing antigens, has been described as a possible antigenic 
carbohydrate epitope in xenotransplantation.  Nonhuman mammals including 
baboons and chimpanzees express the sialic acid Neu5Gc whereas humans 
express only N-acetylneuraminic acid (Neu5Ac) due to a mutation in the cytidine 
monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene (77).  
 17 
Known carbohydrate antigen comparisons between domestic pigs, GTKO pigs 
and humans are summarized in Figure 1-11.  The CMAH enzyme converts CMP-
Neu5Ac to CMP-Neu5Gc in the cytosol and then transported into the golgi to be 
conjugated to oligosaccharides on glycoproteins (78).  Human serum was 
determined to have antibodies towards Neu5Gc (79) and CMAH / α1,3-
galactosyltransferase double knockout mice studies demonstrated cytotoxicity of 
human antibodies towards Neu5Gc (80).  Despite these studies, the importance 
of the Neu5Gc carbohydrate antigen continues to be controversial due to the 
clinical successes obtained in concordant Neu5Gc positive xenografts trials.  
GTKO pig-to-nonhuman primate xenotransplant models continue to demonstrate 
antibody-mediated rejection where the HD antigen is present in both host and 
recipient suggesting the presence of other antigenic epitopes.  The Neu5Gc 
carbohydrate as an antigenic epitope for GTKO pig fibronectin was investigated 
in chapter 4. 
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Objectives Addressed 
Our studies focus on understanding, evaluating and identifying possible 
genetic targets for modification to attenuate liver xenotransplant associated 
thrombocytopenia and antibody-mediated rejection necessary to make clinically 
applicable organ xenotransplantation a reality.  The immediate obstacle to liver 
xenotransplantation has been identified as thrombocytopenia. Platelet clearance 
due to liver sinusoidal cell phagocytosis, pig and human platelet receptors and 
platelet carbohydrate differences were explored as mechanisms for 
xenotranplant associated thrombocytopenia. Potential genetic targets to 
attenuate thrombocytopenia were evaluated.  Antibody-mediated rejection 
continues to be a barrier to heart and kidney transplantation despite generation 
of GTKO pigs.  Focused initial evaluation of a known GTKO pig glycoprotein 
xenoantigen, fibronectin, was completed following methodologies required to 
validate and examine pathologic antigenic epitopes.  The HD carbohydrate 
antigen involvement in GTKO pig fibronectin antigenicity was explored. 
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Figure 1-1. Comparison of the number of patients on the waiting list to patients 
transplanted from 1995-2010.  Greater growth in number of patients added on to 
the waiting list (solid line) compared to number of patients transplanted (dashed 
line).  (United Network of Organ Sharing database) 
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Figure 1-2. Statue of Ganesha the god of wisdom depicted with the characteristic 
elephant’s head acquired through xenotransplantation based on Hindu 
mythology.  
 
  
Ganesha Stele. 11th century. Portland Art 
Museum, Portland, Oregon. March 8, 2013. 
http://www.portlandartmuseum.org. 
  
Location: Bihar or Bengal, India, or 
Bangladesh.  
 
Time Period: 11th century Pala Period 
 
Medium: gray schist.  
 
Dimensions: 35 3/4 in x 18 in x 6 in.  
 
Collection: Asian Art. 
 
Type of art: Sculpture.  
 
Museum Purchase: Funds provided by 
exchange through gifts of Mr. and Mrs. 
Hugh McCall 
 
Statement of Use: Materials are included 
under the fair use exemption and are 
restricted from further use. 
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Figure 1-3. Summary of potential xenotranplantion treatments for a variety of 
diseases from Ekser 2012 (7). 
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Figure 1-4. Zinc finger nuclease diagram from Maeder 2009 .  The zinc finger 
array is designed to bind a specific nucleotide sequence to target a specific gene.  
When combined with the Fok1 non-specific DNA cleavage domain, a double 
strand DNA break may occur leading to deletion or insertion of base pairs 
following non-homologous end joining. 
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Figure 1-5. Comparison of pig-to-nonhuman primate xenograft longest survival 
per organ type in number of days.  Lung and liver xenografts have distinctly lower 
survival compared to heart and kidney. 
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Figure 1-6. Ex vivo porcine liver perfusion circuit and human platelet perfusion 
graph from Burlak 2010 (53).  Domestic porcine livers were harvested and 
connected to the circuit shown below.  Human and pig platelets were circulated 
through the pig liver demonstrating rapid clearance of human platelets within 
minutes after perfusion. 
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Figure 1-7. Diagram of the liver sinusoidal cells and platelet recognition and 
confocal images of domestic pig liver biopsies at various time intervals after 
perfusion of labeled human platelets using ex vivo circuit from Burlak 2010 (53).  
Labels are as follows: CD31 (red) labeling endothelial cells, Carboxyfluorescein 
succinimidyl ester (CFSE)-labeled human platelets (green), and CD107a (blue) 
denoting lysosomes.  Human platelets begin to bind to the liver sinusoidal 
surface (white arrows) with subsequent fusion with lysosomes to form 
phagosomes (yellow arrows) and eventual movement of CFSE into hepatocytes 
(red arrow). 
  
Adapted from MIT OpenCourseWare liver sinusoidal cells diagram under the 
creative commons license agreement: http://ocw.mit.edu/terms/ 
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Figure 1-8. Chilled platelet clearance model adapted from Hoffmeister 2011 (59).  
Platelets with increased exposure of terminal N-acetylglucosamine are 
recognized by αMβ2 integrin (CD11b/CD18, complement receptor 3, macrophage 
antigen complex 1).  Platelets with increased terminal galactose are recognized 
by Hepatic lectin 1 (HL1) and Hepatic lectin 2 (HL2) also known as 
Asialoglycoprotein receptors 1 and 2.  Platelets with sialic acids that cap 
exposure of terminal N-acetylglucosamine and galactose continue to circulate. 
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Figure 1-9. Antibody-mediated rejection model. Human antibodies recognize 
graft resulting in complement activation and damage to graft endothelial cells.  
Contraction and damage to endothelial cells expose the extracellular matrix 
resulting in platelet activation and thrombosis leading to downstream ischemia 
and eventual graft loss. 
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Figure 1-10. (A) Diagram representation of the exposure of normally hidden 
physiologic antigenic epitopes resulting from denaturation of a glycoprotein. (B)  
Normal human serum antibody recognition of native conformation and heat 
denatured human albumin.  Native conformation albumin travels farther on the 
gel due secondary protein structure.  Denatured human albumin is recognized by 
both normal serum IgM and IgG. 
 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
 29 
Figure 1-11. Diagram for known carbohydrate antigens between domestic pigs, 
α1,3 galactosyltransferase knockout (GTKO) pigs and humans.  Domestic pigs 
express galactose α1,3 galactose (αGal) and N-glycolylneuraminic acid 
(Neu5Gc) containing carbohydrates known as Hanganutziu-Deicher antigens 
(HD).  GTKO pigs lack the αGal oligosaccharide on glycoproteins but continue to 
express Neu5Gc.  Humans express N-acetylneuraminic acid (Neu5Ac) and lack 
αGal and Neu5Gc expression. 
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ABSTRACT 
Background: Hepatic failure has been treated successfully with clinical 
extracorporeal perfusions of porcine livers.  However, dog to pig and pig to 
baboon liver xenotransplant models have resulted in severe bleeding secondary 
to liver xenograft-induced thrombocytopenia.  Kupffer cells (KC) are abundant 
phagocytic cells in the liver.  Kupffer cells express the CD11b/CD18 receptor, 
which has been implicated in chilled platelet binding and phagocytosis through 
interaction with platelet surface proteins and carbohydrates.  We sought to 
identify the role of KC CD18 in liver xenograft induced thrombocytopenia.   
Methods: Primary pig KC were characterized by flow cytometry, immunoblot and 
quantitative PCR.  Pig KC were used in inhibition assays with fluorescently 
labeled human platelets.  The CD18 receptor was targeted for siRNA 
knockdown.   
Results: Domestic and α1,3-galactosyltransferase double knockout porcine KC 
cultures were ~92% positive for CD18 as detected by qPCR and flow cytometry.  
Use of CD18 blocking antibodies resulted in reduction of human platelet binding 
and phagocytosis.  Additionally, asialofetuin, not fetuin, inhibited platelet 
phagocytosis suggesting the involvement of an oligosaccharide binding site.  
Furthermore, reduced CD18 expression by siRNA, resulted in decreased human 
platelet binding. 
Conclusions:  Our data suggest primary pig KC bind and phagocytose human 
platelets with involvement of CD18.  Further understanding and modification of 
CD18 expression in pigs may result in a liver xenograft with reduced 
 45 
thrombocytopenic effects, which could be used as a bridge to allogeneic liver 
transplantation. 
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INTRODUCTION 
The major barrier to liver xenotransplantation is thrombocytopenia that 
occurs minutes after graft reperfusion (1, 2).  Non-human primates transplanted 
with a α1,3-galactosyltransferase knockout (GTKO) porcine liver xenograft 
survive for 4-7 days despite the loss of platelets (1).  In an ex vivo pig liver 
perfusion model, human platelets were removed by sinusoidal endothelial cells 
and Kupffer cells (KC) (3). 
KC have the capacity to phagocytose large numbers of cells during 
xenogeneic interactions.  Pig KC exposed to normal human blood during a 
normothermic ex vivo pig liver perfusion phagocytosed nearly all the erythrocytes 
from three units of human blood in 72 hours (4).  Xenogeneic uptake of human 
erythrocytes is caused, in part by a disparity between pig and human 
carbohydrates expressed on the erythrocyte surface (5).  KC have also been 
implicated in phagocytosis of cold activated platelets through the heterodimer 
CD11b/CD18 through the recognition of exposed β-glucans, specifically β-N-
acetyl D glucosamine (β-GlcNac) (6-8).  CD18 forms heterodimers with CD11a, 
b, c, d which comprise the family of cell surface receptors, β2 integrins, which are 
expressed on macrophages and are involved in binding bacterial cell wall 
proteins, facilitating cellular adhesion, cell-cell interactions and phagocytosis (9-
11).  The necessity of CD18 and the formation of heterodimers with CD11a, b, c, 
d in binding and phagocytosis of platelets is unclear.  However, specific point 
mutations in CD18 abolished ligand recognition by the receptors CD11a/CD18 
and Mac-1 implicating the importance of CD18 in receptor-ligand interaction (12).  
 47 
Mac-1 differs from other β2 integrins in that CD11b has a β-glucan binding 
domain capable of binding β-GlcNac (13).  In addition, Mac-1 has been shown to 
bind foreign fungal oligosaccharides containing β-GlcNac, also found on 
autologous-branched chains on the extracellular matrix and glycoproteins on 
mammalian cells (14). 
The production of the GTKO pig has made it possible to consider using a 
pig liver for temporary life support as a bridge to allotransplantation.  The loss of 
platelets in the immediate reperfusion period represents a barrier that must be 
overcome before liver xenotransplantation can be applied clinically.  The 
mechanism for platelet loss in the liver xenotransplant setting is currently 
unknown.  Porcine liver KC and liver sinusoidal endothelial cells are involved in 
xenotransplantation-induced thrombocytopenia (3).  In this manuscript, evidence 
is presented which shows that the CD18 cell surface receptor on domestic and 
double α-galactosyltransferase knockout/human decay accelerating factor 
transgenic (GTKO/hDAF) porcine Kupffer cells bind and induce phagocytosis of 
human platelets in vitro. 
  
 48 
RESULTS 
Kupffer cells isolated from porcine liver sinusoids express macrophage 
markers  
 Primary porcine domestic and GTKO/hDAF KC were isolated to study 
their role in xenogeneic thrombocytopenia.  Day-three live cultured primary 
porcine GTKO/hDAF KC under 10x magnification or fixed under 40x 
magnification and Giemsa stained had a characteristic slightly indented 
macrophage nuclear morphology (Figure 2-1A).  There were no histological 
differences observed between domestic and GTKO/hDAF porcine KC.  Primary 
KC from domestic and GTKO/hDAF pigs were positive for macrophage markers 
CD11b, CD14, CD18 and CD45 by flow cytometric analysis with gate set on 
propidium iodide-negative cells (Figure 2-1B).  The live cell population had 
uniform histograms with average values of 92.5% (domestic) and 91.3% 
(GTKO/hDAF) KC purity based on macrophage markers.  The anti-CD18 
monoclonal blocking antibody with cross reactivity with porcine CD18 was used 
for flow cytometric analysis (15).  Domestic and GTKO/hDAF porcine KC have a 
statistically significant higher relative gene expression of CD11b and CD18 
compared to RNA profiles of domestic and GTKO/hDAF porcine whole liver using 
unpaired Student’s t-test (Figure 2-1C).  Isolated and cultured primary domestic 
and GTKO/hDAF fibroblasts were used as negative control for Mac-1 expression 
(n=3, p<0.05) (Figure 2-1C).  These results suggest that KC are the predominant 
source of Mac-1 in the liver.  Measurements of CD11b and CD18 mRNA levels 
between domestic and GTKO/hDAF KC, pulmonary alveolar macrophages, 
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splenic macrophages and peripheral blood monocytes were not statistically 
different using one-way ANOVA and Neuman-Keuls multiple comparison tests 
indicating similarity in gene expression for Mac-1 (data not shown). 
Pig Kupffer cells bind and phagocytose human platelets in vitro 
 To assess KC ability to bind and phagocytose platelets, in vitro assays 
and confocal microscopy were used. Domestic and GTKO/hDAF porcine KC 
rapidly bound and phagocytosed more human platelets compared to autologous 
platelets (n=2-5, p<0.05) (Figure 2-2A) demonstrating xenogeneic platelet uptake 
in vitro.  The highest rate of platelet uptake occurred in the first 15 minutes after 
incubation with platelets.  Unlabeled platelets and KC had low levels of auto-
fluorescence, which contributed minimally to the detectable fluorescence of 
CFSE-labeled human platelets. 
Confocal microscopy of domestic and GTKO/hDAF KC in culture 
demonstrated the ability of KC to bind and phagocytose platelets and expression 
of CD18 and CD11b receptors on porcine Kupffer cells.  Confocal analysis 
revealed that CFSE-labeled platelets (green) co-localized with CD11b (red) rich 
areas in the cell shown in the merged confocal image (orange) (Figure 2-2B, 
yellow arrows).  Porcine CD18 (red) also co-localized (orange) with human 
platelets (green) at various stages of degradation in what are likely phagosomes 
(Figure 2-2C, yellow arrows).  
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Inhibition of human platelet binding and phagocytosis by domestic and 
GTKO/hDAF pig Kupffer cells 
Experiments to prevent KC from phagocytosing human platelets were 
undertaken utilizing two methods of inhibition.  Fetuin, a glycoprotein composed 
of sialic acid terminated β-glucans had no inhibitory effects on KC platelet uptake 
at concentrations tested (Figure 2-3A).  However, asialofetuin (fetuin with 
terminal sialic acids removed exposing more β-glucans including β-GlcNac 
oligomers) had significant levels of platelets blocked from binding and 
phagocytosis in a dose-dependent manner (2-3A).  Inhibition of human platelet 
phagocytosis was shown as a ratio of asialofetuin to fetuin control treatment at 
each concentration.  Domestic KC were inhibited from binding human platelets 
with asialofetuin by 35% (5mg/mL), 72% (10mg/mL) and 75% (20mg/mL) (n=2-7) 
(Figure 2-3A).  Kupffer cells isolated from GTKO/hDAF pigs were inhibited with 
asialofetuin by 47% (5mg/mL), 60% (10mg/mL), 76% (20mg/mL) (n=2-3) (Figure 
2-3A).  Inhibition percentages between concentrations for both domestic and 
GTKO/hDAF pig KC reached statistical significance using one-way ANOVA (n=2-
7, p<0.05) with Newman Keuls post hoc test when 5 mg/mL was used.  No 
statistical difference was observed between the 10mg/mL and 20mg/mL 
treatments. 
The mouse anti-CD18 blocking antibody used to identify CD18 expressing 
KC in 2-1B, and 2-2C was used to inhibit human platelet binding and 
phagocytosis in a dose-dependent manner represented as anti-CD18 blocking 
antibody normalized to IgG1k isotype control treatment at each dose.  Human 
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platelets were inhibited from phagocytosis by domestic pig KC by 43% 
(2.5ug/mL), 70% (5ug/mL) and 73% (10ug/mL) (n=2-7) compared to no treatment 
(Figure 2-3B).  Kupffer cells from GTKO/hDAF pigs were inhibited by 18% 
(2.5ug/mL), 31% (5ug/mL) and 55% (10ug/mL) (n=2-3) (Figure 2-3B).  Percent 
inhibition between no treatment and antibody treatment for both domestic and 
GTKO/hDAF porcine KC were statistically significant using one-way ANOVA and 
Neuman-Keuls multiple comparison tests (n=2-3, p<0.05). 
siRNA inhibition of platelet binding 
To study the CD18 receptor more directly, porcine CD18 antisense RNA 
oligos were designed, incubated with ferrous beads and used for transfection of 
primary domestic and GTKO/hDAF KC.  The results were statistically significant 
with a 27% and 26% decrease in CD18 transcript levels, respectively for 
domestic (n=3, p<0.05) and GTKO/hDAF (n=3, p<0.05) KC when compared to 
siGenome negative control, non-specific antisense off-target oligos using an 
unpaired Student’s t-test (Figure 2-4A).  CD18 protein expression from replicate 
domestic and GTKO/hDAF KC cultures showed a 24% and 11% decrease in 
CD18 receptor expression, respectively (n=3, p<0.05) (Figure 2-4A).  Ferrous 
bead-siRNA treated KC were used in the human platelet binding and 
phagocytosis assay to determine the functional effect of reduced CD18 
expression.  Human platelet binding and phagocytosis was reduced by 31.5% 
(n=3, p<0.05) and 13.5% (n=3) for domestic and GTKO/hDAF KC, respectively 
(Figure 2-4C).  Although platelet binding and phagocytosis for CD18 siRNA 
treated GTKO/hDAF was not statistically significant, there was a trend towards 
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decreased platelet binding similar to domestic KC.  No statistical difference was 
found between siGenome and untreated group for mRNA transcript levels, 
receptor expression and platelet binding and phagocytosis (data not shown).  
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MATERIALS AND METHODS 
Production of GTKO/hDAF pigs 
Double α1,3galactosyltransferase knockout / human decay accelerating 
factor cells were acquired from the National Swine Resource and Research 
Center (NSRRC:0009) at the University of Missouri and cultured in Dulbecco's 
Modified Eagle Medium with 15% FBS and allowed to grow to confluence and 
then harvested (24).  A single GTKO/hDAF cell was injected into matured 
enucleated in vitro oocytes (Minitub of America, Mount Horeb, WI and/or ART 
Madison WI, USA).  Electrical pulses induced fusion and activation (25), and 
resulting embryos were transferred to a recipient on the first day of estrous.   
Pig liver procurement 
Domestic (primarily Landrace breed) and GTKO/hDAF (Miniature 
background) pigs, weighing 22-45kg, were anesthetized, intubated, prepped with 
chlorohexidine and draped in sterile fashion.  The liver was dissected, excised, 
flushed with 2 liters of histidine-tryptophan-ketoglutarate preservation solution 
(Essential Pharmaceuticals. LLC, Newtown, PA) and stored on ice until time of 
cell isolation.  Cadaveric domestic pig livers were also harvested from the 
abattoir in similar fashion within 2 minutes of exsanguinations with the exception 
of performing a liver flush with heparin-containing preservation solution. 
Isolation of Kupffer cells 
Procured chilled porcine livers were flushed with 0.0125ug/mL 
collagenase type IV (Sigma, St. Louis, MO) diluted in Hanks’ balanced salt 
solution (HBSS) (Sigma-Aldrich, St. Louis, MO).  Cells were pelleted by 
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centrifugation at 400 x g at room temperature, erythrocytes lysed using 
ammonium chloride solution, washed with phosphate buffered saline (PBS), then 
washed with PBS containing 1mM EDTA.  Cells were cultured in polystyrene 
plates in the incubator in RPMI-1640 medium supplemented with 10% fetal 
bovine serum (v/v), 10mM HEPES, penicillin-streptomycin and amphotericin B.  
Cultures were washed after one hour incubation with generous amounts of PBS 
then HBSS to remove non-adherent cells.  Cultures were washed daily with 
HBSS until assayed on day 3. 
Platelet isolation and preparation 
 Fresh human or porcine whole blood was collected in anticoagulant citrate 
dextrose (ACD) and centrifuged for 3 minutes.  Platelet-rich plasma was 
collected and centrifuged at 5000 x g for 5 minutes.  Platelets were re-suspended 
and washed with PBS. Platelets used for in vitro KC assays were incubated and 
labeled with carboxyfluorescein succinimidyl ester (CFSE) (Invitrogen, Carlsbad, 
CA) for 30 minutes then washed with PBS.  Platelets were stored at room 
temperature and used within a few hours. 
Flow cytometry 
KC were released from culture plates on day 3 using 12mM lidocaine in 
PBS at 37°C (26).  Cells were blocked with PBS containing 0.5% BSA, 0.02% 
sodium azide and stained with anti-CD11b (American Type Culture Collection, 
Manassas, VA. HB-249), anti-CD14 (R&D Systems, Minneapolis, MN.), anti-
CD18 (Developmental Studies Hybridoma Bank, Iowa City, IA, H52) and anti-
CD45 (ABD Serotec, Raleigh, NC.) for one hour followed by two washes with 
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buffer. Mouse isotypes IgG1k and IgG2b (eBioscience, San Diego, CA.) were used 
as negative control. Propidium iodide staining was used to exclude dead cells.  
Goat anti-mouse IgG PE (Jackson ImmunoResearch Laboratories, West Grove, 
PA.) was used as secondary.  All flow cytometry data was collected and 
analyzed on the Accuri C6 flow cytometer and CFlow software (Accuri, Ann 
Arbor, MI). 
Histological Analysis of Kupffer cells 
Live cultured and Giemsa stained KC microscopy was completed using 
Olympus CX41, CKX41 microscopes.  Confocal microscopy was performed 
using a Olympus IX81/FV1000 microscope.  For confocal analysis, KC were 
incubated with CFSE-labeled platelets for 1 hour at 37 °C, fixed in 4% 
paraformaldehyde, permeabilized with 0.2% Triton-X 100, blocked with 1% BSA 
in PBS.  Cells were labeled with anti-CD18 or anti-CD11b, followed by donkey 
anti-mouse IgG DyLight 649 (Jackson ImmunoResearch Laboratories, West 
Grove, PA) and mounted with Prolong Gold with DAPI (Invitrogen, Carlsbad, 
CA).  Slides were imaged using settings from the negative controls.  A dashed 
white line was used to mark the outer membranes of each cell by increasing 
background fluorescence. Scans were run in sequential mode to prevent cross 
over between channels.  
In vitro Kupffer cell-platelet binding, phagocytosis and inhibition assay  
Primary KC, 1 x 106 per well, were cultured for 3 days at 37 ºC (5% CO2) 
in opaque black wall-clear bottom cell culture-treated 96-well plates.  Human and 
porcine platelets were isolated and labeled simultaneously and plated in empty 
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wells in eight dilutions as platelet fluorescence standard.  Labeled platelets (4 x 
106) were added to wells containing KC.  Plates were centrifuged at 2000 x g to 
synchronize platelet settling. Replicate wells for each time point were washed 
with PBS three times then fixed with 4% paraformaldehyde in PBS for 20 
minutes.  After obtaining all time points, fluorescence was measured using a 
SpectraMax M2e plate reader (Molecular Devices Corp. Sunnyvale, CA).  Assays 
comparing human and porcine platelets were completed on the same plate.  
Differences in fluorescence between human and porcine platelets were 
accounted for by a factor determined by the ratio between human and porcine 
platelet fluorescence standards.  Adjusted fluorescent values were averaged and 
the highest value for each experiment was set to 100%.  This normalization 
enabled comparison of data collected from different days by eliminating the 
technical variability.  Wells containing KC without labeled platelets were used to 
determine and subtract auto-fluorescence.  Inhibition assays were performed in 
similar manner with wells treated with anti-CD18 antibody, mouse IgG1k isotype 
control, or asialofetuin and fetuin (Sigma-Aldrich, St. Louis, MO) for 30 minutes 
prior to the addition of platelets. 
siRNA knockdown of CD18 
KC cultured for one day were washed with HBSS and fresh medium 
added.  During optimization siGenome transfected, mock transfected with Purple 
NIMT beads (Genovis, Sweden) and non-transfected KC showed no significant 
differences in protein expression.  Purple NIMT beads with CD18 or siGenome 
control siRNA (Dharmacon, Chicago, IL) were incubated for 30 minutes at room 
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temperature.  Following incubation, the bead mixture was added to KC cultures 
at 60 pmol/mL final and 15uL 1 x NIMT beads/mL final.  The target sequence for 
CD18 siRNA was sense strand: CCAAGUUUGCUGAGCGCUAAA and anti-
sense strand UAGCGCUCAGCAAACUUGGAA. On day 3 of culture, 48 hours 
after addition of the siRNA bead complex, cells were incubated with platelets for 
the uptake assay or RNA was harvested for qPCR analysis.  Knockdown was 
analyzed by qPCR using CD18 probes (Applied Biosystems: CD11b AssayID-
Ss03374593_m1, CD18 AssayID-Ss03392626_u1) described above and whole 
liver control in a comparative CT experiment on a STEP-ONE PLUS (Applied 
Biosystems, Carlsbad, CA) real time PCR system or by In-Cell Western™ Assay 
Kit (LI-COR Biosciences Lincoln, Nebraska) using the H52 anti-CD18 blocking 
antibody without cell permeabilization. 
Statistical analysis 
GraphPad Prism software was used for graphical and statistical analyses 
using paired and unpaired Student’s t-tests, one-way ANOVA and Newman-
Keuls multiple comparison tests. 
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DISCUSSION 
Liver xenotransplantation-induced thrombocytopenia prevents the use of 
porcine liver xenografts as a bridge to allotransplantation (1, 2). Both pig KC and 
liver sinusoidal endothelial cells have been shown to phagocytose human 
platelets in ex vivo pig liver perfusion (3).  Understanding the mechanisms by 
which these cells recognize and phagocytose human platelets would generate 
targets for genetic modifications of donor pigs to prevent xenogeneic 
thrombocytopenia.  Mouse Mac-1 antigen binds cold-stored platelets that have 
exposed β-GlcNac bearing oligosaccharides (7).  The ability of the Mac-1 antigen 
to bind ligands is dependent on the I-domain, recognizing amino-acid sequences, 
and the lectin-binding domain, recognizing β-glucans (14, 16, 17).  The 
cytoplasmic tail of CD18 interacts with the cytoskeleton suggesting direct 
involvement with receptor trafficking or phagocytosis (18).  Involvement of the 
Mac-1 receptor for both non-opsonic and opsonic phagocytosis has been 
demonstrated (19).  Analysis of leukocyte adhesion deficiency syndrome, a 
disease caused by the lack of CD18, indicates that CD18 is critical for maturation 
and expression of CD11a, b, c and the ability of Mac-1 antigen to recognize a 
ligand (12, 20).  Studies completed on CD18-deficient mice showed a decreased 
ability to bind and phagocytose β-glucans (21).  Therefore, we studied the role of 
porcine KC CD18 receptor in liver xenograft-induced thrombocytopenia. 
 We confirmed that our isolated cells had morphological characteristics and 
cell surface markers consistent with KC, including the ability of CD18 blocking 
antibody (clone H52) to recognize porcine CD18 (22).  The H52 anti-CD18 
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antibody was used for flow cytometry, confocal microscopy and inhibition of 
CD18 function in platelet phagocytosis.  Platelet uptake assays as well as 
confocal microscopy verified that isolated KC bound and phagocytosed human 
platelets in vitro.  Co-localization of CD18 and CD11b receptors with platelets 
suggest that these receptors are involved with human platelet phagocytosis.  
CD18 inhibition assays resulted in a moderate reduction of platelet phagocytosis 
compared to the isotype control indicating that the blocking antibody does not 
completely abolish binding functions of porcine CD18 or that other receptors may 
be involved.  It is also possible that intracellular stores of CD18 were mobilized to 
the cell surface when KC were treated with blocking antibody (23).  To evaluate 
the involvement of platelet carbohydrates, inhibition assays with the 
glycoproteins asialofetuin and fetuin were undertaken.  Asialofetuin treatment of 
KC resulted in substantial reduction in platelet binding and phagocytosis in 
comparison to fetuin, indicating the involvement of a lectin-binding domain such 
as in Mac-1.  Asialofetuin has exposed β-GlcNac oligomers, however, many 
other oligosaccharides are exposed, implicating possible involvement of other 
lectin receptors. 
To further define CD18 receptor involvement and to demonstrate that 
decreased CD18 gene expression attenuates platelet uptake, primary porcine KC 
CD18 knockdown was studied using siRNA.  Knocking down gene expression 
using siRNA is difficult in primary cells especially terminally differentiated KC.  
The use of primary KC for siRNA was challenging due to variability in their 
maturation or differentiation state, primary cell resistance to chemical transfection 
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reagents and anionic nature of siRNA.  There have been several methods used 
recently to target phagocytic cells using iron-oxide nanoparticles.  Although we 
employed this technique, knockdown of primary KC CD18 mRNA expression 
proved difficult. CD18 protein expression may have been hampered by the 
presence of Mac-1 stores that exceed the protein’s turnover time relative to 
CD18 mRNA production (23).  Nonetheless, there was a corresponding decrease 
in CD18 receptor and platelet phagocytic functions supporting the hypothesis that 
a decrease in CD18 would reduce platelet binding and phagocytosis.  The 
reduction of platelet phagocytosis by siRNA knockdown supports the CD18 
antibody blocking and substrate inhibition results. 
Our results show that CD18 is involved in liver xenotransplantation-
induced thrombocytopenia suggesting that reduction or elimination of CD18 
expression in pigs may yield a xenograft with reduced thrombocytopenic effects.  
The inhibition of platelet uptake by blocking CD18 was pronounced, but 
incomplete, which emphasizes the need for further investigation of CD18/CD11b 
and other receptors.  The present study focuses on Kupffer cells but our prior 
studies demonstrated that liver sinusoidal endothelial cells also bind and 
phagocytose human platelets (3).  Together, these studies suggest that receptors 
expressed by KC and liver sinusoidal endothelial cells should continue to be 
investigated. 
  
 61 
Figure 2-1. Histological, flow cytometric and quantitative mRNA analyses of day 
3 cultured domestic and GTKO/hDAF porcine KC.  (A) Representative light 
micrograph [n=10] of isolated KC (10x) on left and Giemsa stained light 
micrograph (40x) [n=10] on right.  (B) Flow cytometric histograms for 
macrophage markers (red) CD11b, CD14, CD18, CD45 [n=3] of domestic and 
GTKO/hDAF KC with isotype control (black).  (C) Relative mRNA comparisons of 
CD11b and CD18 between isolated domestic and GTKO/hDAF KC, liver and 
fibroblasts (negative control) with values normalized to liver. *Indicate statistical 
significance (p<0.05, n=3). 
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Figure 2-2. In vitro platelet binding and phagocytosis and confocal microscopy.  
(A) Plot of fluorescence representing percent human platelets bound and 
phagocytosed by domestic and GTKO/hDAF porcine KC at various time points 
shown with +/- 1 standard deviation bars. Domestic and GTKO/hDAF KC 
phagocytosis of human platelets was statistically significant compared to 
phagocytosis of autologous domestic platelets (n=2-5, p<0.05) and GTKO/hDAF 
platelets (n=2-5, p<0.05).  (B) Confocal micrographs of domestic and 
GTKO/hDAF KC binding and phagocytosing human platelets with staining for 
CD11b.  (C) Confocal micrograph of domestic and GTKO/hDAF KC binding and 
phagocytosing human platelets with staining for CD18.  Outer membrane of cells 
was defined with a dashed white line.  Images are representative of three 
biological replicates. 
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Figure 2-3. Inhibition of human platelet phagocytosis by domestic and 
GTKO/hDAF porcine KC by asialofetuin and anti-CD18 blocking antibody.  (A) 
Graphical representation of inhibition of human platelet phagocytosis by fetuin 
and asialofetuin treatments normalized to a non-treated control. Error bars 
represent +/- 1 standard deviation plotted against 5, 10 and 20 mg/mL 
concentrations were statistically significant for both domestic (n=3, p<0.05) and 
GTKO/hDAF (n=3, p<0.05) compared to no treatment and fetuin treated KC.  (B) 
Anti-CD18 blocking of human platelet phagocytosis normalized to an isotype 
control with +/- 1 standard deviation. *Indicates statistical significance compared 
to no treatment (n=3, p<0.05).  **Indicates statistical significance compared to all 
other values (n=3, p<0.05). 
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Figure 2-4. CD18 siRNA knockdown of CD18 mRNA, protein and phagocytosis 
of domestic and GTKO/hDAF porcine KC.  (A) Domestic and GTKO/hDAF 
porcine KC CD18 mRNA (%) measured by quantitative PCR.  (B) Domestic and 
GTKO/hDAF porcine KC surface CD18 expression (%) measured by In-Cell 
Western™.  (C) Domestic and GTKO/hDAF porcine KC human platelet 
phagocytosis (%) with no platelet KC autofluorescence control measured by in 
vitro platelet assay.  All error bars represent +/- 1 standard deviation. *Indicates 
statistical significance (n=3, p<0.05). 
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Chapter 3 
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ABSTRACT 
Background: Acute thrombocytopenia was revealed as a limiting factor to 
porcine liver xenotransplantation from in vitro and in vivo studies using porcine 
liver in human and baboon transplant models.  The asialoglycoprotein receptor 1 
(ASGR1) on liver sinusoidal endothelial cells (LSEC) and Macrophage Antigen 
Complex-1 (Mac-1) on Kupffer cells (KC) mediate platelet phagocytosis and have 
carbohydrate-binding sites that recognize galactose and N-acetyl glucosamine in 
the beta conformation.  Analysis of these receptor carbohydrate-binding domains 
and surface carbohydrates on human and porcine platelets may shed light on the 
mechanism of xenotransplantation-induced thrombocytopenia. 
Methods: An amino acid sequence comparison of human and porcine ASGR1 
lectin binding domains was performed.  Using fluorescent labeled-lectins, human 
platelets, domestic and α1,3 galactosyltransferase knockout/human decay 
accelerating factor (GTKO/hDAF) porcine platelets were characterized by flow 
cytometry and lectin blot analyses.  After desialylation, human and porcine 
platelets were examined by flow cytometry to determine if sialic acid capping of 
galactose and N-acetyl glucosamine oligosaccharides in the beta conformation 
was a factor.  Further, desialylated human platelets were studied on primary 
porcine liver sinusoidal cells with regard to binding and phagocytosis.  
Results: Human platelets have four times more exposed galactose β1-4 N-acetyl 
glucosamine (Galβ) and N-acetyl glucosamine β1-4 N-acetyl glucosamine 
(βGlcNAc) than fresh porcine platelets.  Galβand βGlcNAc moieties on porcine 
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platelets were not masked by sialic acid.  Removal of sialic acid from human 
platelets increased binding and phagocytosis by LSEC and KC. 
Conclusions: Differences between human and porcine ASGR1 and Mac-1, in 
combination with a significantly higher number of galactose and N-acetyl 
glucosamine-containing oligosaccharides on human platelets contribute, in part, 
to platelet loss seen in porcine liver xenotransplantation. 
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INTRODUCTION 
Acute thrombocytopenia observed during liver xenotransplantation is 
mediated partially by liver sinusoidal cells.  Both the asialoglycoprotein receptor-1 
(ASGR1) and Macrophage Antigen Complex-1 (Mac-1) participate in this process 
as knockdown of these proteins using siRNA resulted in a decrease in human 
platelet phagocytosis by porcine liver sinusoidal cells in vitro (1, 2).  ASGR1, a 
component of the Ashwell receptor expressed on liver sinusoidal endothelial cells 
(LSEC), has a carbohydrate-binding site that recognizes exposed galactose β1-4 
N-acetyl glucosamine (Galβ) (1).  Kupffer cells express Mac-1, which contains a 
carbohydrate-binding site for N-acetyl glucosamine β1-4 N-acetyl glucosamine 
(βGlcNAc) oligosaccharides (3-5).  Human platelet binding to porcine liver 
sinusoidal cells partially depends on the availability of carbohydrate binding sites 
based upon competition experiments using the glycoproteins fetuin and 
asialofetuin (1, 2).   
The liver clears platelets from the circulation in normal and disease states 
including senescent platelets, cold-stored transfused platelets and during 
Streptococcus pneumoniae induced-sepsis (6-8).  Loss of sialic acid from the 
surface of platelets during S. pneumoniae infection by the bacterium’s 
neuraminidase induced Ashwell receptor-mediated platelet phagocytosis in mice 
(6).  Mac-1 and ASGR1 mediated platelet phagocytosis also occurs with cold-
stored platelets used for donation because there is an increase in both 
concentration and density of βGlcNAc and Galβ (7, 9).  In both cases, the sialic 
acid was suggested to shield galactose and N-acetyl glucosamine 
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oligosaccharides, protecting platelets from uptake (6, 8).  The same receptors 
are involved in xenogeneic platelet uptake, cold-stored platelet uptake and 
platelet uptake during S. pneumoniae induced-sepsis, hence the mechanism 
may be similar and analysis of these carbohydrates on human and porcine 
platelets may elucidate the means of xenotransplantation-induced 
thrombocytopenia. 
Orthologs of ASGR1 from various mammals including humans, mice, and 
rats have high sequence identity (10).  All natural mammalian forms of ASGR1 
studied have a high binding affinity for terminal β-linked galactose or N-
acetylgalactosamine (11-13).  Some endogenous ligands for rat ASGR1 were 
found to be glycoprotein hormones with terminating Siaα2,6GalNAcβ1,4GlcNAc 
oligosaccaharides and not β-linked galactose or N-acetylgalactosamine (14).  A 
comparison of ASGR1 from different species examining specificity for 
glycoproteins with terminal Siaα2,6GalNAcβ1,4GlcNAc revealed that even with 
very few differences in amino acid (AA) sequence there can be large changes in 
carbohydrate specificity (10).   
 Mac-1 orthologs have subunits exhibiting high similarity as well as 
subunits exhibiting significant differences in binding affinities (15, 16).  Antibodies 
against cd11b, the α subunit of Mac-1, from various species were not found to 
react across species (15).  In contrast, antibodies against cd18, the β subunit of 
Mac-1 cross-react among species (15).  This indicates that the differences 
among species most likely occur in cd11b, the subunit containing the predicted 
carbohydrate-binding motif.  Rat and human cd11b have significant differences in 
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affinity for the glycoprotein, recombinant neutrophil inhibitory factor (16).  
Variation in the CD11b sequence among species contributes to differences in 
ligand affinity.  
In this study, the porcine ASGR1 sequence was identified and the 
carbohydrate-binding site was predicted based on the known crystal structure of 
human ASGR1.  The predicted human and porcine CD11b carbohydrate binding 
motifs were compared.  Variations in human and porcine ASGR1 and Mac-1 in 
combination with significantly higher endogenous levels of galactose and N-
acetyl glucosamine-containing oligosaccharides may explain in part the 
phenomenon of liver xenotransplantation-induced thrombocytopenia. 
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MATERIALS AND METHODS 
Structural and sequence analysis of ASGR1, sequence analysis of CD11b 
 The porcine ASGR1 protein sequence was translated using the Swiss 
Institute of Bioinformatics expert protein analysis system (SIB EXPASy) from the 
sequence AK233544.1 in the NCBI database.  Porcine and human ASGR1 
sequences were aligned and compared.  The structural images were created 
using Pymol Molecular Graphics System (DeLano, W.L., World Wide Web.2002).  
Human ASGR1 binding domain (protein data bank: 1DV8) was superimposed 
with GlcNAc (protein data bank:1CBJ).  Porcine ASGR1 binding domain was 
predicted by altering R262 to G262 in Pymol. 
 The Sus scrofa integrin alpha-M AA sequence (GenBank: AEE80503.1) 
was aligned with the homo sapiens integrin alpha-M isoform 1 precurser 
(GenBank: AAA59544.1) AA sequence using (Basic Local Alignment Search 
Tool- Protein) BlastP  (NCBI), the protein sequence alignment algorithm.  A 
BlastP comparison was also done with only the predicted carbohydrate-binding 
region and with the rest of the sequence without the predicted carbohydrate-
binding domain (17-20).  Positive matches include non-identical conserved 
substitutions using the BLOSUM26 scoring matrix (NCBI).    
Platelet preparation 
Human and porcine platelets were isolated from fresh whole blood 
containing anticoagulant citrate phosphate dextrose by centrifugation of whole 
blood at 2000 x g for 3 minutes, and then centrifugation of platelet enriched 
plasma at 5000 x g for 5 minutes.  Platelets were resuspended in phosphate 
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buffered saline (PBS); some were labeled with carboxyfluorescein succinimidyl 
ester (CFSE) (Invitrogen, Carlsbad, CA) and counted using a hemocytometer.  
Immunoblot/lectin blot analysis 
Platelets were lysed in Laemmli sample buffer with Focus protease arrest 
(G-bioscience, Maryland Heights, MO) and heat denatured at 95°C.  Samples 
were analyzed using SDS-PAGE and immunoblot or lectin blot.  Membranes 
were blocked with 50% Odyssey blocking buffer (LI-COR Biosciences, Lincoln, 
NE) in HBSS for 1 hour followed by incubation with anti-GAPDH (Millipore, 
Billerica, MA), anti-beta actin (Rockland Immunochemicals for Research 
Gilbertsville, PA) according to manufacturer recommended specifications.  
Membranes also were probed with erythrina cristagalli (ECA)-biotin, succinylated 
wheat germ agglutinin (sWGA)-biotin, and Datura strumonium (DSA)-biotin (EY 
laboratories, San Mateo, CA).  Following primary antibody or lectin binding, 
membranes were probed with the appropriate secondary antibody or streptavidin 
conjugated to either IRDye 800CW or IRDye 680CW (LI-COR Biosciences, 
Lincoln, NE).  Blots were scanned with a LI-COR near-infra-red Odyssey scanner 
(LI-COR Biosciences, Lincoln, NE).  
Flow cytometry 
Human, domestic, or GTKO/hDAF porcine platelets were washed then 
stained using lectins from EY Laboratories, (San Mateo, CA) as follows: ECA 
Lectin to determine quantity of galβ residues; sWGA lectin, to determine 
βGlcNAc oligosaccharides, or DSA lectin to determine βGlcNAc and Galβ 
residues.  Anti-CD22/Siglec 2-FC (Invitrogen, Carlsbad, CA) was used to 
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measure exposed α2,6-linked N-glycolylneuraminic acid (Neu5Gc) (1mg/mL 
each).  All platelets were washed and stained in 50% HBSS (Sigma, St. Louis 
MO) and 50% PBS with 0.02% sodium azide, 0.5% BSA.  Secondary antibodies 
and avidin conjugates were used according to manufacturer’s recommendations.  
Sialidase treatment and quantification 
Human, domestic porcine, and GTKO/hDAF platelets (5 x 108/mL PBS) 
were treated with 1/8 U Sialidase A for 1 hour at room temperature.  Following 
treatment, platelets were collected by centrifugation.  Platelets were labeled with 
CFSE for binding and phagocytoisis assays or stained for flow cytometric 
analysis.   
Porcine liver procurement 
GTKO/hDAF pigs were obtained from the National Swine Resource and 
Research Center (NSRRC) or produced from cells obtained from NSRRC 
(NSRRC 0009; www.nsrrc.missouri.edu).  Livers from domestic or genetically 
modified pigs were removed as described by (1, 2).  Briefly, the liver was 
removed and perfused through the portal vein with 1-2L cold histidine-
tryptophan-ketoglutarate (HTK) solution (Essential Pharmaceuticals, LLC. 
Newtown, PA).  Some livers were procured from the abattoir and flushed with 
HTK containing heparin (2000U/L) within 2 minutes of exsanguination.  All livers 
were stored at 4°C until placed in the perfusion circuit.  Cold-ischemia time was 
less than 3 hours. 
Isolation of Liver Sinusoidal Endothelial Cells and Kupffer Cells 
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Cold porcine livers were placed in a chilled container (4°C) and flushed 
with 0.025% of collagenase type IV from Clostridium histolyticum (Sigma, St. 
Louis, MO) at 37°C.  LSEC and KC were isolated by centrifugation and selective 
adherence as previously described (1, 2). 
In vitro platelet binding assay  
Primary KC or LSEC were cultured for 3 or 4 days, respectively, at 37 ºC 
and 5% CO2 in black walled-clear bottomed, cell culture-treated, 96-well plates 
(100,000 cells/well).  Four million CFSE-labeled platelets were added to wells 
containing primary KC or LSEC and medium.  The assay was performed as 
previously described (1, 2).  In short, following addition of platelets, plates were 
centrifuged at 2000 x g for 3 minutes.  Wells with endothelial cells or Kupffer cells 
without CFSE-labeled platelets were used to determine levels of auto 
fluorescence.  In LSEC and KC experiments the normalized fold change 
following sialidase treatment compared to no treatment was plotted.   
Statistical Analysis 
Data was analyzed using Graphpad Prism 5 (La Jolla, CA).  Student’s t-
test, ANOVA, and Tukey Post-Hoc multiple comparison tests were performed as 
indicated in figure legends. 
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RESULTS 
Sequence analysis, structural modeling of the ASGR1 binding site, and 
sequence analysis of CD11b 
 The sequence for ASGR1 in the porcine genome database (AK233544.1) 
was identified using the human sequence as a reference (assn: M10058).  After 
translation of the nucleotide sequence, the AA sequences were aligned.  The 
Galβ binding site identified in human ASGR1 (21) was 3 AA different from 
porcine ASGR1 (Figure 3-1A).  The predicted porcine ASGR1 structure was 
compared to the published human ASGR1 structure (pdb: 1DV8) (Figure 3-1B). 
 The sequence identity between porcine and human CD11b was 79% and 
the positive matches were 87% when compared using NCBI Blastp.  The 
proposed human and porcine CD11b carbohydrate-binding motifs (17, 19, 22) 
were aligned and compared (Figure 3-1C).  There are multiple differences in AA 
with a significant number being non-conserved residues.  The carbohydrate-
binding motif of porcine CD11b had 70% sequence identity and 83% positive 
matches when compared with that of human CD11b.  This is lower in sequence 
identity than the rest of CD11b excluding the carbohydrate-binding motif; identity 
80%, positive matches 88%.  
Concentrations of Galβ and βGlcNAc on platelets  
 Domestic and GTKO/hDAF porcine platelets had similar amounts of 
exposed Galβ and βGlcNAc as measured by flow cytometry using the lectins 
ECA (Figure 3-2A), sWGA (Figure 3-2B) and DSA (Figure 3-2C).  Galβ on 
human platelets was 68.8% and 64.9% higher than on the domestic and 
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GTKO/hDAF porcine platelets respectively (n=3, p<0.05) (Figure 3-2A).  
βGlcNAc on human platelets was 74.6% greater than the βGlcNAc expression on 
domestic porcine platelets (n=3, p<0.05) and 77.2% higher compared to 
GTKO/hDAF porcine platelets (n=3, p<0.05) (Figure 3-2B).  Total Galβ and 
βGlcNAc on human platelets was 73.2% greater than the expression on domestic 
porcine platelets (n=3, p<0.05) and 85.1% higher compared to GTKO/hDAF 
porcine platelets (n=3, p<0.05)(Figure 3-2C).  The fluorescence intensities of 
ECA lectin, sWGA lectin and DSA lectin did not differ significantly between 
domestic and GTKO/hDAF porcine platelets using one-way ANOVA and the 
Tukey post Hoc test, however both differed significantly from human (Figure 3-2).  
Membranes with porcine and human platelet lysates were probed with ECA, 
sWGA, DSA lectins and revealed that numerous proteins are glycosylated with 
terminal Galβ or βGlcNAc oligosaccharides (Figure 3-2). 
The role of sialic acid on Galβ and βGlcNAc availability 
Human and porcine platelets were treated with sialidase A to remove 
terminal α2,3 and α2,6 Neu5Ac and Neu5Gc exposing Galβ and βGlcNAc 
epitopes.  Human platelets treated with sialidase had 2.0 (n=6, p<0.05) fold more 
exposed Galβ epitopes compared with mock treated platelets (Figure 3-3A) and 
5.1 (n=3, p<0.05) and 6.4 (n=3, p<0.05) fold more exposed Galβ epitopes 
compared to treated-domestic and GTKO/hDAF porcine platelets, respectively 
(Figure 3-3A).  Human platelets treated with Sialidase A had a 2.1 (n=3, p<0.05) 
fold increase in exposed βGlcNAc epitopes compared with mock treated platelets 
(Figure 3-3B).  Following treatment with Sialidase A, human platelets had 6.26 
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(n=3, p<0.05) and 5.4 (n=3, p<0.05) fold more sWGA lectin binding for domestic 
and GTKO/hDAF porcine platelets (Figure 3-3B).  Total Galβ and βGlcNAc on 
human platelets increased by 2.8 (n=3, p<0.05) fold following Sialidase A 
treatment (Figure 3-3C).  Human platelets had 4.7 (n=3, p<0.05) and 7.9 (n=3, 
p<0.05) fold more total Galβ and βGlcNAc compared to domestic and 
GTKO/hDAF porcine platelets, respectively, after treatment with sialidase (Figure 
3-3C).  In fact, the sialidase treatment of the pig platelets produced only a slight 
increase in reactivity of the various lectins tested.  None of the lectins tested 
differed significantly between domestic and GTKO/hDAF porcine platelets for 
binding (Figure 3-3).   
LSEC and KC phagocytosis of desialylated human platelets 
To investigate the functional effects of increased exposure of Galβ and 
βGlcNAc oligosaccharides on sialidase-treated human platelets, in vitro assays 
were completed with domestic and GTKO/hDAF LSEC and KC.  Desialylated 
human platelets incubated with domestic porcine LSEC or GTKO/hDAF porcine 
LSEC had a statistically significant 2.4 (n=5, p<0.05) and 2.2 (n=5, p<0.05) -fold 
increase in phagocytosis, respectively, when compared to mock-treated platelets 
(Figure 3-4A).  Sialidase-treated human platelets incubated with domestic 
porcine KC and GTKO/hDAF porcine KC had a statistically significant 2.7 (n=6, 
p<0.05) and 1.9 (n=5, p<0.05) fold increase in platelet phagocytosis respectively 
suggesting the importance of platelet surface carbohydrates (Figure 3-4B).  Data 
was analyzed using Student’s t-test.  
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DISCUSSION 
The basis of xenogeneic phagocytosis of human platelets via lectin 
receptors including ASGR1 and Mac-1 expressed on liver sinusoidal cells has 
not been well characterized.  Most human platelets bind and are taken up by 
LSEC and KC within 15-30 minutes following addition, in vitro and ex vivo.  There 
are multiple factors that may exist at the root of xenogeneic platelet 
phagocytosis.  First, differences in receptor sequence and structure between pig 
and human may lead to differences in the binding capabilities and specificity of 
ligand.  Another hypothesis is that there are differences in ligand concentration 
and density between human and porcine platelets.  The data presented here 
indicates that it is most likely a combination of differences in receptor and ligand 
between human and pig.   
ASGR1 and Mac-1 have been studied extensively with regards to binding 
specificity of Galβ and βGlcNAc (3, 23-31). It was found that livers from closely 
related mammals have distinct capacities to bind Galβ and Siaα2,6GalNAc (10).  
In particular, porcine liver extract showed very little binding capacity for 
Siaα2,6GalNAc (10).  Recombinant mouse and human ASGR1 showed very little 
binding to Siaα2,6GalNAc, in contrast to rat ASGR1 differing in 12 AA shows a 
dramatic difference in ASGR1 binding capacity (10).  Studies using mutant 
chimeras of rat and mouse ASGR1 indicate that small changes in AA sequence 
can reflect changes in affinity of ligand (10).  Even though there are only 3 A.A. 
differences between porcine and human ASGR1, they are within the binding site 
and most likely yield differences in ligand binding affinity.  When comparing the 
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predicted Mac-1 carbohydrate-binding domain of human and pig, there are many 
differences in the AA sequence between pig and human.  With over half of the 
differences being non-similar AA, it is likely that porcine and human Mac-1 will 
differ in specificity and avidity for binding Galβ and βGlcNAc.   
The xenogeneic uptake of human platelets by the porcine liver may in part 
be explained by differences in receptor affinity, but it may also be explained in 
part by differences in ligand.  The known ligand for ASGR1 is terminal Galβ, 
while Mac-1 binds terminal Galβ and βGlcNAc oligosaccharides.  These 
oligosaccharides are on both proteins and lipids covering the surface of platelets 
(32-34).  Galβ and βGlcNAc, as seen by our data of platelet lysates on 
membranes probed with lectins, are on multiple proteins in both human and 
porcine platelets.  There are reported differences between bovine and human 
platelets with respect to carbohydrate composition (32).  Miyagawa et al. 
reported that there are differences between human and GTKO porcine 
endothelial cells and fibroblasts (35).  In particular human endotheial cells 
showed stronger reactivity with ECA than the porcine endothelial cells (36).  The 
porcine and human platelets exhibit differences in both Galβ and βGlcNAc 
amounts on the extracellular plasma membrane, as seen by the flow cytometric 
analysis.  This difference in ligand concentration likely contributes to the 
xenogeneic uptake of platelets.  
The removal of aged platelets from the circulation takes place following 
the loss of terminal sialic acid on the branched chain N and O linked 
oligosaccharides comprising platelet glycoproteins and glycolipids (8, 36).  
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However, there is convincing evidence that normal platelet uptake is more likely 
due to expression of markers of apoptosis and not sialic acid content (37, 38).  A 
function of the ASGR1on KC and hepatocytes is to mediate removal of platelets 
that have been desialylated by bacterial neuraminidase, which exposes 
underlying galactose containing oligosaccharides during sepsis (6, 39, 40).  
These desialylated platelets were rapidly removed from circulation by the liver.  
In vitro removal of sialic acid from rabbit platelets caused an increase uptake in 
vivo following injection (41).  It seems plausible that porcine primary LSEC and 
KC recognize human platelets as mice recognize bacteria-induced desialated 
platelets (6).  By desialylating human and porcine platelets it was found that the 
release of sialic acid did not equalize the Galβ or the βGlcNAc differences 
between humans and pigs.  Rather human platelet Galβ and βGlcNAc 
oligosaccharide exposure was increased while maintaining dramatically higher 
levels compared to the pig platelet, which translated to an increase in 
phagocytosis by primary porcine LSEC and KC.  This parallels work done by 
Greenberg et al that found compared to other mammalian species there was little 
difference following desialation of porcine platelets with regards to aggregation 
indicating that there is little sialic acid capping on the pig platelet (41).  Previous 
work proposed that Galβ epitopes on desialylated platelets were targets for 
ASGR1 in the liver (6, 8, 39, 40).  When the enzyme that adds sialic acid to the 
galactose, St3gal4, was knocked out there was systemic dysregulation of 
thrombosis resulting in prolonged bleeding (8).  The non-sialylated platelets from 
these mice were removed from circulation resulting in 66% of platelets removed 
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in 2.8 minutes (8).  The xenogeneic uptake of human platelets by porcine LSEC 
and KC is not likely a result of differences in sialic acid capping, but a result of 
differences in the basal level of exposed Galβ and βGlcNAc between human and 
porcine platelets. 
 
CONCLUSIONS 
Variation in ASGR1 and Mac-1 sequences between species within the 
carbohydrate binding domains are present.  Humans have more Galβ and 
βGlcNAc epitopes available compared to porince platelets regardless of 
sialylation state.  Desialylation of human platelets increases available Galβ and 
βGlcNAc epitopes, thus increasing human platelet uptake by porcine sinusoidal 
cells. 
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Figure 3-1. Comparison of Human and Porcine ASGR1 and CD11b.  (A) A 
comparison of human and porcine ASGR1 saccharide binding sites revealed 
three amino acid (AA) differences (yellow boxes).  An arginine in the human 
sequence is a glycine in the porcine sequence, possibly altering the availability of 
the binding pocket (box).  (B) The human (protein data bank: 1DV8) and pig 
ASGR1 binding sites were constructed using the Pymol Molecular Graphics 
System with an N-acetylglucosamine (protein data bank: 1BCJ) in the binding 
site.  A black arrow indicates the human arginine 262 that is glycine 262 in pigs.  
(C) A comparison of human and porcine CD11b predicted carbohydrate-binding 
domain.  AA differences highlighted (yellow), dissimilar, non-conserved 
differences boxed. 
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Figure 3-2. Differences in Galb and bGlcNAc between human and porcine 
platelets.  (A) Flow cytometric analysis of Galb levels on human, domestic, and 
a1,3galactosyltransferase knockout (GTKO)/human decay accelerating factor 
(hDAF) porcine platelets measured by erythrina cristagalli (ECA) lectin binding 
represented by the mean fluorescent index.  A representative histogram is 
shown. Immunoblot/Lectin blot analysis of human, domestic, and GTKO/hDAF 
porcine platelet lysates for Galb using ECA and GAPDH (indicated by arrow). (*) 
(n = 3, ANOVA/Tukey’s test compared with Human P < 0.05).  (B) Flow 
cytometric analysis of bGlcNAc levels on human, domestic, and GTKO/hDAF 
porcine platelets measured by succinylated wheat germ agglutinin (sWGA) lectin 
binding represented by the mean fluorescent index.  A representative histogram 
is shown. Immunoblot/Lectin blot analysis of human, domestic, and GTKO/hDAF 
porcine platelet lysates for bGlc-NAc using sWGA and b actin indicated by arrow. 
(*) (n = 3, ANOVA/Tukey’s test compared with Human P < 0.05).  (C) 
Flow cytometric analysis of bGal and bGlcNAc levels on human, domestic, and 
GTKO/hDAF porcine platelets measured by Datura stramonium (DSA) lectin 
binding represented by the mean fluorescent index. A representative histogram is 
shown.  Immunoblot/Lectin blot analysis of human, domestic, and GTKO/hDAF 
porcine platelet lysates for bGal and bGlcNAc usingDSAand b actin indicated by 
arrow. (*) (n = 3,ANOVA/Tukey’s test compared with Human P < 0.05).  
 92 
 
 93 
Figure 3-3. Differences in total Galb and bGlcNAc levels between human and 
porcine platelets are not a result of differences in relative sialylation.  (A) Flow 
cytometric analysis of Galb levels on human, domestic, and 
α1,3galactosyltransferase knockout (GTKO)/human decay accelerating factor 
(hDAF) porcine platelets following sialidase treatment or mock treatment using 
erythrina cristagalli lectin binding represented as the mean fluorescent index.  A 
representative histogram from three experiments is shown (n = 3, 
ANOVA/Tukey’s test P < 0.05, *Compared with human mock-treated, 
**Compared with human sialidase-treated).  (B) Flow cytometric analysis of 
bGlcNAc levels on human, domestic, and GTKO/hDAF porcine platelets following 
sialidase treatment or mock treatment using sWGA lectin binding represented as 
the mean fluorescent index. A representative histogram from three experiments 
is shown. (n = 3, ANOVA/Tukey’s test P < 0.05, *Compared with human mock-
treated, **Compared with human sialidase-treated).  (C) Flow cytometric analysis 
of human, domestic pig, and GTKO/hDAF porcine platelets for bGal and 
bGlcNAc acid using Datura strumonium following sialidase or mock treatment.  
Representative histogram from three experiments is shown. (n = 3, 
ANOVA/Tukey’s test P < 0.05, *Compared with human mock-treated, 
**Compared with human sialidase-treated). 
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Figure 3-4. Removal of Sialic acid from human platelets increases capture by 
Domestic and a1,3galactosyltransferase knockout (GTKO)/human decay 
accelerating factor (hDAF) porcine liver sinusoidal endothelial cells (LSEC) and 
Kupffer cells (KC).  Human platelets either mock-treated or treated with sialidase 
for 1 h, labeled with carboxyfluorescein succinimidyl ester and incubated with 
domestic and GTKO/hDAF porcine (A) LSEC or (B) KC for 15 or 30 min 
respectively.  Captured platelets were measured with a Spectramax plate reader 
for fluorescence (n = 5).  Data analyzed using Student’s t-test at P < 0.01. 
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ABSTRACT 
Background: Antibody-mediated rejection continues to be an obstacle for 
xenotransplantation despite development of α1,3-galactosyltransferase knockout 
(GTKO) pigs.  Fibronectin (Fn) from GTKO pigs was identified as a xenoantigen 
in baboons.  N-glycolylneuraminic acid (Neu5Gc), similar to galactose α1,3-
galactose, is an antigenic carbohydrate found in pigs.  We evaluated human 
antibody reactivity and performed initial antigenic epitope characterization of Fn 
from GTKO pigs. 
Materials and Methods: GTKO pig aortic endothelial cells (AEC) were isolated 
and assessed for antibody-mediated complement dependent cytotoxicity (CDC).  
Human and GTKO pig Fns were purified and analyzed using immunoblots.  
GTKO pig and human AEC absorbed human sera were assessed for CDC and 
anti-GTKO pig Fn antibodies.  GTKO pig proteins were assessed for Neu5Gc. 
Immunoaffinity-purified human IgG anti-GTKO pig fibronectin (hIgG-GTKOp Fn) 
using a GTKO pig Fn column were evaluated for cross-reactivity with other 
proteins.  
Results: GTKO pig AEC had greater human antibody binding, complement 
deposition and CDC compared to allogeneic human AEC.  Human sera absorbed 
with GTKO pig AEC resulted in diminished anti-GTKO pig Fn Ab.  Neu5Gc was 
identified on GTKO pig Fn and other proteins.  The hIgG-GTKOp Fn cross-
reacted with multiple GTKO pig proteins and was enriched with anti-Neu5Gc 
antibody. 
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Conclusions: Removal of antigenic epitopes from GTKO pig AEC would 
improve xenograft compatibility.  GTKO pig Fn has antigenic epitopes, one 
identified as Neu5Gc, which may be responsible for pathology and cross-
reactivity of hIgG-GTKOp Fn.  Genetic knockout of Neu5Gc appears necessary 
to address significance and identification of non-Neu5Gc GTKO pig Fn antigenic 
epitopes. 
 
 
Keywords: xenotransplantation, xenoantigen, fibronectin, antibody-mediated 
rejection, N-glycolylneuraminic acid, Neu5Gc 
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INTRODUCTION 
Antibody-mediated rejection (AMR) is a barrier demonstrated in pig to 
non-human primate transplant models despite creation of α1,3-
galactosyltransferase gene knockout (GTKO) pigs (1-9).  Removal of other 
antigens appears necessary to prevent AMR. 
Fibronectin (Fn), a glycoprotein produced by endothelial cells, was 
identified as a xenoantigen in GTKO pig to baboon cardiac transplant studies (1).  
Glycoproteins are of special interest, because in addition to antigenic peptides, 
antigenic glycosylations, for example galactose α1,3-galactose (αGal) 
carbohydrate antigen, may be shared by multiple pig glycoproteins.  Similarly, N-
glycolylneuraminic acid (Neu5Gc), a foreign sialic acid equivalent of N-
acetylneuraminic acid (Neu5Ac) in humans, is found on pig glycoproteins and 
was identified as an antigen demonstrated by the presence of cytotoxic anti-
Neu5Gc antibodies in normal human sera (10-13).  The significance of the 
Neu5Gc antigen for xenotransplantation continues to be controversial (14). 
Discovery of new antigenic epitopes responsible for AMR is necessary to 
identify new genetic targets for modification.  Given that knockout of the Fn gene 
was lethal in mice (15) and Fn is involved in many cellular activities including cell 
growth, adhesion, migration, differentiation, coagulation, pathogen opsonization, 
wound healing, embryogenesis (16, 17), characterization of pig Fn epitopes is 
necessary.  We characterized the reactivity of preformed human antibodies 
towards endothelial cells and Fn purified from GTKO human CD55 transgenic 
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pigs (GTKOp) to evaluate its potential role in AMR and to identify potential 
antigenic epitopes for modification. 
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MATERIALS AND METHODS 
Source of Pigs and Procurement of Tissue 
GTKOp were produced through somatic-cell nuclear transfer using cells 
from the National Swine Resource and Research Center (NSRRC:0009) at the 
University of Missouri.  After pigs were anesthetized, the abdominal and thoracic 
cavities were entered followed by cannulation of the aorta and histidine-
tryptophan-ketoglutarate solution (Essential Pharmaceuticals. LLC, Newtown, 
PA) flush.  Liver and kidney frozen sections were obtained followed by harvest of 
the aorta.  Samples were taken from 3 different pigs. 
Aortic Endothelial Cell Isolation  
 The GTKOp aortic thoracic and abdominal branches were tied off.  Aortas 
were filled with 0.0125ug/mL collagenase type IV (Sigma-Aldrich, St. Louis, MO) 
diluted in Hank’s balanced salt solution (HBSS) and incubated at 37°C for 30min.  
The collagenase and endothelial cell mix was transferred into a 50mL conical 
tube and centrifuged at 400xG for 10min. Cells were re-suspended in Medium 
200 with Low Serum Growth Factor Supplement (Invitrogen, Carlsbad, CA) and 
plated.   
Flow Cytometry 
Isolated GTKOp cells and human AEC (Invitrogen) were trypsinized, 
washed and stained in phosphate buffer saline (PBS) with 0.5% bovine serum 
albumin (BSA) and 0.02% sodium azide using mouse anti-CD31 IgG1 (Santa 
Cruz Biotechnology, Santa Cruz, CA), mouse anti-swine leukocyte antigen (SLA) 
Class 1 IgG1 (ABD Serotec, Raleigh, NC), mouse anti- human leukocyte antigen 
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(HLA) Class 1 ABC IgG1k (BD, Franklin Lakes, NJ), mouse IgG1 isotype (ABD 
Serotec) and mouse IgG1k isotype (eBioscience, San Diego, CA) and donkey 
anti-mouse IgG Dylight®649 (Jackson ImmunoResearch Laboratories, West 
Grove, PA) was used for detection.  Heat inactivated human sera were incubated 
with GTKOp and human AEC at various dilutions ranging from 0 to 50% for 1.5 
hours, followed by washes with PBS.  Donkey anti-human IgM Dylight®649 and 
IgG Dylight®649 (Jackson ImmunoResearch) were used for detection.  Flow 
cytometry was performed and analyzed on the Accuri™C6 flow cytometer 
(Accuri, Ann Arbor, MI).  Flow histograms were used to characterize isolated 
AEC.  Mean fluorescence index values were recorded for human antibody 
recognition of AEC. 
Confocal Microscopy  
Frozen tissue sections and cell monolayers were fixed with 4% 
paraformaldehyde.  Tissues were permeabilized but not cell monolayers. GTKOp 
kidney sections were stained with goat anti-CD31 IgG (R&D Systems, 
Minneapolis, MN), mouse anti-beta-actin IgG (Sigma-Aldrich) and sheep anti-
fibronectin IgG (ABCAM, Cambridge, MA) and detected using bovine anti-goat 
IgG Dylight®488 (Jackson ImmunoResearch), donkey anti-sheep IgG Alexa 
Fluor®555 (Invitrogen) and anti-mouse IgG Dylight®649.  GTKOp liver sections 
were stained with the same antibodies as above except for mouse anti-human 
CD18 IgG1 (Developmental Studies Hybridoma Bank, Iowa City, IA) instead of 
beta-actin. Sheep, goat IgG isotype (SouthernBiotech, Birmingham, AL) and 
mouse IgG isotype (Santa Cruz) were used as controls.  GTKOp and human 
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AEC were stained with mouse anti-CD31 and sheep anti-fibronectin primary 
antibody (Ab) and anti-sheep Alexa Fluor®555, anti-mouse IgG Dylight®649 
secondary Ab.  Live GTKOp AEC and human AEC were incubated with heat 
inactivated human serum at various dilutions or number of cell absorptions in 
HBSS for 1.5hr and washed with warm HBSS three times. Slides were fixed and 
stained with donkey anti-human IgM Dylight®549 and IgG Dylight®649 (Jackson 
ImmunoResearch) or incubated with baby rabbit complement (Cedarlane, 
Burlington, NC), fixed and stained with sheep anti-human C4 IgG (ABD Serotec) 
followed by anti-sheep Alexa Fluor®555.  Nuclei were stained with DAPI.  
Neu5Gc images were obtained using the Sialix®Gc-Free kit (Sialix, Vista, CA) in 
conjunction with donkey anti-chicken IgY Dylight®649 (Jackson 
ImmunoResearch).  Quantification images were obtained separately in triplicate 
using the photon count acquisition setting.  Images were taken using an Olympus 
IX81/FV1000 microscope 60x/1.40 oil objective and analyzed on FluoView 
software.  Image sets were captured using consistent laser and detector settings 
and processed with consistent brightness and contrast settings in Adobe 
Photoshop®CS4. 
Purification of Fibronectin and Human Antibodies 
 Human and GTKOp Fns were affinity purified from plasma using Gelatin 
Sepharose™4B  (GE Biosciences, Pittsburg, PA) column.  Trace contaminants 
were removed using two serial Sephacryl™S-400 size exclusion columns 25mm 
(diameter) x 500mm (height) (GE Biosciences).  Fns were desalted in Tris 
buffered saline (TBS) using 100kDa centrifugal concentrators.  GTKOp Fn was 
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conjugated with CNBr-activated Sepharose™4B at 5mg/mL (protein/mL of 
beads) for a 5mL total column bed volume.  Total human IgG was purified from a 
blood group O donor with a HiTrap™Protein G column (GE Biosciences).  
Human anti-GTKOp Fn IgG were immunoaffinity-purified by application of 100mg 
of 5mg/mL total human IgG to the column, washed with TBS, eluted with TBS 4M 
urea and desalted to yield 70µg of IgG estimated using the Nanodrop®1000 
(Thermoscientific, Wilmington, DE).  All liquid chromatography was performed on 
a BioLogic Duoflow system (Bio-Rad, Hercules, CA). 
Protein Preparation and Immunoblot Analysis 
Fibronectins were normalized based on OD280 measurements taken on 
SpectraMax®M2e (Molecular Devices, Sunnyvale, CA). GTKOp Fn and sera and 
human Fn, sera and albumin were diluted into TBS 100mM 
ethylenediaminetetraacetic acid (EDTA) 10% glycerol pH 7.5 buffer.  Ground 
frozen GTKOp liver and kidney and Escherichia coli DH10B™strain (Invitrogen) 
were solubilized and lysed in TBS 1% Igepal CA-630 (NP-40 substitute) 10% 
glycerol pH 8 on ice for 30min followed by three freeze-thaw cycles, 
centrifugation at 4°C and collection of supernatant.  Electrophoresis was 
accomplished using the Criterion™ system and 4-10% TGX™ precast gels (Bio-
Rad), Tris Glycine buffer with or without 0.1% SDS corresponding to denaturing 
or native conditions.  Fns were separated under native conditions whereas 
GTKOp tissue lysates and sera were analyzed under denaturing conditions along 
with E. coli positive and human albumin negative controls.  Proteins were 
transferred to polyvinylidene difluoride (PVDF) membranes or stained with Bio-
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Safe Coomassie (Bio-Rad).  Membranes were blocked with Odyssey Blocking 
Buffer (LI-COR, Lincoln, NE) then incubated with human sera at 10%, total 
human IgG at 1mg/mL, hIgG-GTKOp Fn at 10ug/mL or sheep anti-fibronectin at 
1ug/mL.  After washes with PBS, blots were probed with goat anti-human IgG 
IRDye®800CW or IgM IRDye®800 (Rockland Immunochemicals, Gilbertsville, 
PA) or anti-sheep IgG Dylight®649 (Jackson ImmunoResearch).  Neu5Gc 
immunoblots were completed with Sialix®Gc-Free kit (Sialix) and donkey anti-
chicken IgY IRDye®800CW (LI-COR). Blots were scanned on the Odyssey 
infrared imaging system (LI-COR).  
Antibody-mediated Complement Dependent Cytotoxicity Assay 
 Absorbed human sera were prepared by dilution to 50% in HBSS followed 
by seven serial applications to confluent monolayers of GTKOp and human AEC 
in two-chamber coverglass slides.  Antibody absorption was analyzed by 
confocal microscopy as described above.  Sera dilutions ranging from 0-50% 
were incubated in triplicate with confluent GTKOp or human AEC for 2hr, washed 
with warm HBSS then incubated with 12.5% baby rabbit complement for 1hr.  
WST-1 Cell Proliferation Assay System (Takara, Mountain View, CA) was used 
to assess cell viability and growth. 
Enzyme linked immunosorbent assay (ELISA) and Mass Spectometry 
 Neu5Gc/Neu5Ac-polyacrylic acids (500ng/mL) and goat anti-human 
IgG/IgM H+L chain F(ab’)2 (Jackson ImmunoResearch) (10ug/mL) were coated 
onto plates using carbonate bicarbonate pH 9.5 buffer. GTKOp Fn was coated at 
20ug/mL in PBS.  Recombinant human albumin (Sigma-Aldrich) (1%) in PBS 
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was used for blocking and antibody/sera dilutions.  Serum ranging from 0-25% 
were incubated in duplicate with coated plates for 4hrs, then bound antibody was 
detected using goat anti-human IgM Fc5µ or IgG Fcγ F(ab’)2 HRP (Jackson 
ImmunoResearch) and o-Phenylenediamine dihydrochloride with acid stop.  
Standard curves were generated from purified human IgM and IgG (Sigma-
Aldrich).  Absorbance at 490nm was measured and data analyzed using 
SpectraMaxM2e and SoftMaxPro®5 software (Molecular Devices).  HRP 
secondary antibody only measurements were subtracted as background.  
Antibody measurements for Neu5Ac were subtracted as background from 
Neu5Gc.  Measurements of diluted serum incubated in blocked wells followed by 
secondary Ab was recorded as non-specific background binding.  Proteins were 
identified using the AB SCIEX TOF/TOF™5800 System as previously described 
(18). 
Statistical Analysis 
GraphPad Prism 5 (Prism, La Jolla, CA) was used for generation of graphs and 
statistical analyses.  Flow cytometric, confocal and absorbance measurements 
used for Figures 4-1C, 4-1F, 4-3B and 4-3C were normalized to the highest value 
per serum used on GTKOp and human AEC set.  Band intensities in 4-2C were 
normalized relative to the human Fn band for each serum. ELISA measurements 
for Figure 4-3C were normalized using unaltered human serum set at 100%.  
Linear regression and binding saturation non-linear fit analyses were used for 
IgM and IgG respectively in Figure 4-1C.  One-tailed paired Student’s t-test was 
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used for Figures 4-1E, 4-2C, 4-3B, 4-3C and 4-3D.  One-way analysis of 
variance with Tukey’s post hoc test was used to analyze Figures 4-1F, 4-3D. 
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RESULTS  
Preformed Human Antibody-Mediated Complement Dependent Cytotoxicity 
 Flow cytometric analysis demonstrated that isolated GTKOp aortic 
endothelial cells (AEC) were a uniform population of CD31 positive cells similar 
to commercially available human AEC (Figure 4-1A).  The histogram for GTKOp 
AEC Swine Leukocyte Antigen class 1 (SLA1) was comparable to HLA1 in 
human AEC (Figure 4-1A).  Human IgM and IgG bound live GTKOp AEC greater 
than human AEC after incubation with 25% human serum (Figure 4-1B).  Human 
IgM and IgG partially colocalized (Figure 4-1B).  Flow cytometric analysis using 
sera showed greater dose dependent binding of GTKOp AEC by human IgM 
(n=3, p<0.001) and IgG (n=3, p<0.001) compared to human AEC (Figure 4-1C).  
Live GTKOp AEC showed greater complement component 4 (C4) deposition 
than to human AEC after incubation with 5% human serum followed by 
complement (Figure 4-1D).  C4 deposition on GTKOp was 8 fold higher than on 
human AEC, at MFI=122 and MFI=15.8 (n=3, p=0.007) respectively (Figure 4-
1E).  Antibody-mediated complement dependent cytotoxicity (CDC) assay 
showed an initial increase in relative growth and viability for human sera 
incubated with GTKOp AEC or human AEC, followed by a decrease in viability 
for GTKOp AEC (xenogeneic) but not human AEC (allogeneic) in a dose 
dependent manner (n=3, p=0.007) (Figure 4-1F).  The difference between CDC 
curves for GTKOp AEC incubated with GTKOp serum (autologous) and human 
AEC with human serum (allogeneic) were not statistically significant (Figure 4-
1F). 
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Expression and Localization of GTKOp Fibronectin 
 GTKOp kidney and liver express CD31 and Fn (Figure 4-2A).  Beta-actin 
outlines the cellular structures of kidney (Figure 4-2A).  CD18 staining in the liver 
demonstrates Kupffer cells on the surface of liver sinusoidal endothelium (Figure 
4-2A).  CD31, an endothelial cell marker, and Fn colocalized in GTKOp kidney 
and liver (Figure 4-2A).  Non-permeabilized GTKOp AEC and human AEC had 
similar expression of CD31 and Fn on the cell surface (Figure 4-2A).  One band 
for each purified Fn was separated on native Coomassie stained gels and was 
identified as Fn in the anti-Fn immunoblot (Figure 4-2B). GTKOp Fn had four-fold 
greater IgM (n=4, p=0.028) and two-fold greater IgG (n=4, p=0.004) relative band 
intensity compared to human Fn (Figure 4-2B).  E. coli lysate but not human 
albumin was recognized by human IgM and IgG. 
Evaluation of Absorbed Human Sera and Anti-GTKOp Fibronectin 
Antibodies 
 Human sera serially absorbed to GTKOp AEC or human AEC cell 
monolayers seven times showed diminishing IgM and IgG binding to GTKOp 
AEC compared to human AEC (Figure 4-3A).  Human IgM (n=3, p=0.004) and 
IgG (n=3, p=0.012) bound GTKOp AEC more than human (Figure 4-3B).  The 
seventh and final absorption demonstrated continued antibody binding to GTKOp 
AEC by 1.7 fold for IgM and 1.1 fold for IgG compared to human AEC (Figure 4-
3B).  GTKOp AEC absorbed human sera resulted in higher growth and viability 
(n=3, p=0.01) in CDC assays compared to serum absorbed against human AEC 
(Figure 4-3C).  Human sera absorbed with GTKOp AEC compared to human 
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AEC resulted in decreased relative concentrations of GTKOp Fn IgM (83% to 
62%) with background at 32% (n=3, p<0.001) and IgG (106% to 58%) with 
background at 42% (n=3, p=0.005) (Figure 4-3D). 
Assessment of N-glycolylneuraminic Acid on GTKOp Fibronectin, Tissue 
and Cells 
 GTKOp liver, kidney, AEC were positive for Neu5Gc but was minimal for 
human AEC (Figure 4-4A).  Presence of Neu5Gc on GTKOp Fn and mouse 
glycoprotein positive control and not human Fn or human albumin was 
determined by immunoblot analysis (Figure 4-4B).  Neu5Gc was detected on 
multiple proteins in GTKOp serum, kidney and liver lysates, but not in human 
serum (Figure 4-4C). 
Evaluation of Human IgG Antibodies Recognizing GTKOp Fibronectin 
Immunoaffinity-purified human IgG on a GTKOp Fn column (hIgG-GTKOp 
Fn) recognized GTKOp Fn and to a lesser degree human Fn and E. coli (Figure 
4-5A).  Protein G purified total human IgG recognized multiple proteins from E. 
coli, GTKOp kidney and liver lysates while fewer proteins were recognized by 
hIgG-GTKOp Fn (Figure 4-5B).  Fn was not seen by immunoblot (data not 
shown).  One high molecular weight protein band (arrow) in the GTKOp kidney 
lysate was clearly visible in the Coomassie stained gel, total human IgG and 
hIgG-GTKOp Fn immunoblots (Figure 4-5B).  The band was analyzed by mass 
spectrometry leading to identification of several proteins screened based on 
mammalian origin and Molecular Weight Search score (Figure 4-5C).  Original 
sample concentrations for the human anti-GTKOp Fn IgG and total human IgG 
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were 4.125mg/mL and 10.3mg/mL respectively (Figure 4-5D).  Anti-Neu5Gc 
antibodies were detected at 20.75 ng/mL and 8.05 ng/mL from the human anti-
GTKOp Fn IgG and total human IgG respectively representing a 6-fold 
enrichment of anti-Neu5Gc IgG in the hIgG-GTKOp Fn (Figure 4-5D).  
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DISCUSSION 
Preformed human antibodies cause greater antibody-mediated 
complement dependent cytotoxicity to wildtype than to GTKO pig endothelial 
cells (18, 19).  This study demonstrated continued cytotoxicity for GTKOp AEC 
(xenogeneic) and not human AEC (allogeneic) antibody response.  Presence of 
non-αGal antibodies detected through immunoaffinity methods and diminished 
capacity of human sera absorbed with GTKOp AEC to elicit CDC further 
demonstrates the need to remove xenoantigenic epitopes. Fibronectin from 
wildtype pigs was discovered as a xenoantigen with antigenicity attributed mostly 
to αGal (20).  After generation of GTKO pigs, Fn was rediscovered as a 
xenoantigen in pig to baboon cardiac xenotransplantation (1).  Here, we have 
characterized GTKOp Fn antigenicity using normal human sera. 
The relevance of a xenoantigen largely depends on its abundance, 
location and the presence of pathologic antibodies (21).  Data presented here 
demonstrate rich expression of Fn in the vascular space of GTKOp kidney, liver 
and on the surface of endothelial cells suggesting exposure of Fn to host 
antibodies immediately after reperfusion.  Since recent studies suggest that 
autoantibodies to normal and damaged endothelial cells and proteins exist to 
play a role in homeostasis (22-25), one cannot attribute a pathologic significance 
for all antibodies that bind a protein. GTKOp and human Fn were both 
recognized by preformed human antibodies, IgM and IgG recognized native 
GTKOp Fn to a greater extent.  Human sera absorbed to GTKOp AEC resulted in 
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reduced CDC and anti-GTKOp Fn antibodies. These findings implicate antigenic 
epitopes on GTKOp Fn as contributors to CDC. 
Immunoaffinity-purified human anti-GTKOp Fn IgG was cross-reactive 
with multiple GTKOp kidney and liver proteins suggesting the existence of a 
shared antigenic epitope among multiple GTKOp proteins and/or multiple 
antigenic epitopes on GTKOp Fn.  Neu5Gc was found on GTKOp Fn, kidney and 
liver lysates confirming the presence of a known carbohydrate antigen common 
to multiple GTKOp proteins.  Human anti-GTKOp Fn IgG demonstrated affinity 
towards Neu5Gc linked to polyacrylic acid implicating cross reactivity of anti-
Neu5Gc antibodies obtained using GTKOp Fn.  Several studies have shown 
possible increases in Neu5Gc in α1,3-galactosyltransferase deficient pigs (26, 
27) suggesting increased importance of Neu5Gc in GTKO pigs.  Although 
enrichment for anti-Neu5Gc IgG in hIgG-GTKOp Fn implied involvement in the 
antigenicity of GTKOp Fn, anti-Neu5Gc IgG was measured to be a small portion 
of hIgG-GTKOp Fn.  The Neu5Gc and hIgG-GTKOp Fn immunoblots for GTKOp 
kidney and liver lysates were dissimilar and GTKOp fibronectin was also 
identified as a xenoantigen in non-human primates expressing Neu5Gc (1) 
suggesting presence of antigenic non-Neu5Gc epitopes on GTKOp Fn.   
Several proteins were identified in the GTKOp Fn cross-reactive band 
identified in the kidney lysate.  Two out of five proteins identified were cell 
surface transmembrane glycoproteins, which were 4F2 cell-surface antigen 
heavy chain (CD98 heavy subunit, 58 kDa) and low-density lipoprotein receptor-
related protein 2 precursor (megalin, 518 kDa).  Megalin, a known antigenic 
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target responsible for subepithelial glomerular immune deposits for autoimmune 
Heymann nephritis (28, 29), has been studied as a sialoglycoprotein containing 
oligo/polysialic acid, N-linked and O-linked posttranslational glycosylations (30, 
31).  Although the status of Neu5Gc on GTKOp CD98 heavy subunit and megalin 
are currently unknown, the cross-reactive band in the GTKOp kidney lysate was 
positive for Neu5Gc suggesting at least partial responsibility for the observed 
cross-reactivity with GTKOp Fn.  Cross-reactive proteins were evaluated using a 
protein preparation preventing solubilization of Fn in GTKOp kidney and liver 
lysates by use of a mild detergent and cold temperature conditions simplifying 
analysis. 
Xenotransplantation provides a unique opportunity to genetically modify 
donor grafts to enhance compatibility to the host. Comparison of xenogeneic and 
allogeneic CDC indicates the need for antigen removal from GTKOp endothelial 
cells to reach allogeneic levels of immune compatibility.  GTKOp Fn has 
antigenic epitopes, one identified as Neu5Gc, recognized by preformed human 
antibodies.  Since Neu5Gc is a potentially significant xenoantigenic epitope for 
humans, any porcine glycoprotein expressing Neu5Gc could be an important 
xenoantigenic protein. Removal of Neu5Gc through knockout of cytidine 
monophosphate-n-acetylneuraminic acid hydroxylase appears warranted to 
further characterize the importance and identification of non-Neu5Gc GTKOp Fn 
antigenic epitopes. 
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CONCLUSIONS 
Preformed human antibodies still recognize epitopes on porcine 
endothelial cells even in the absence of αGal.  Natural human antibodies bind 
GTKOp Fn.  Natural human antibodies absorbed against GTKOp AEC bind 
GTKOp less and yield reduced CDC suggesting GTKOp Fn has antigenic 
epitopes responsible for CDC.  One epitope on GTKOp Fn is Neu5Gc.  Natural 
human antibodies that bind GTKOp Fn epitopes also bind epitopes on other 
proteins of GTKOp kidney, GTKOp liver, and E.coli.   
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Figure 4-1. Preformed human antibody response to aortic endothelial cells (AEC) 
from α1,3-galactosyltransferase knockout human CD55 transgenic pigs 
(GTKOp).  (A) CD31 (red), SLA1 (blue) and HLA1 (blue) for GTKOp (left) and 
human AEC (right).  (B) Confocal images of GTKOp and human AEC with human 
IgM (green), IgG (red), nuclei (blue) and merge colocalization (yellow) after 
incubation with 25% normal human serum.  (C) Flow cytometric quantification 
represented as relative preformed human IgM (n=3, error bars=SD, p<0.01) and 
IgG (n=3, error bars=SD, p<0.01) binding of GTKOp and human AEC.  (D) 
Confocal images of complement component 4 (C4) deposition onto GTKOp and 
human AEC after incubation with 5% human serum follow by complement.  (E) 
Confocal MFI quantification of C4 deposition onto GTKOp and human AEC (n=3, 
error bars=SD, p<0.05).  (F) Antibody-mediated complement dependent 
cytotoxicity of GTKOp serum on GTKOp AEC, human sera on human AEC and 
human sera on GTKOp AEC (n=3, error bars=SD, p<0.01). 
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Figure 4-2. Evaluation of GTKOp fibronectin (Fn) expression and preformed 
antibody reactivity.  (A) Confocal images of GTKOp kidney, liver, AEC and 
human AEC for CD31 (green), Fn (red), CD18 or beta-actin (magenta), AEC 
isotype controls, nuclei (blue) and merge. Colocalization (yellow) of CD31 and Fn 
in the kidney and liver is shown in the merge.  (B) Coomassie stained gel, Fn, 
total human IgM and IgG immunoblots of E. coli lysate, human albumin, GTKOp 
and human Fn and (C) corresponding band density quantification and 
comparison of GTKOp and human Fn recognizing antibodies (n=4, error 
bars=SD, *p<0.05). 
  
 126 
 
  
 127 
Figure 4-3. Comparison of human sera absorbed with GTKOp or human AEC 
monolayers.  (A) Representative confocal images of serial 1hr absorptions to 
GTKOp or human AEC monolayers.  (B) Confocal MFI quantification and 
comparison of human IgM (n=3, error bars=SD, p<0.01) and IgG (n=3, error 
bars=SD, p<0.05) binding of GTKOp and human AEC monolayers.  (C) Antibody-
mediated complement dependent cytotoxicity comparison of GTKOp and human 
AEC absorbed serum (n=3, error bars=SE, p<0.05).  (D) Relative human anti-
GTKOp Fn IgM and IgG concentration after absorption of human sera to GTKOp 
or human AEC (n=3, error bars=SD, *p<0.001). 
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Figure 4-4. N-glycolylneuraminic acid (Neu5Gc) evaluation on GTKOp 
glycoproteins.  (A) Confocal images of GTKOp liver, kidney, AEC and human 
AEC expression of Neu5Gc (cyan) with isotype controls.  (B) Coomassie stained 
gel, Neu5Gc and Fn immunoblots for mouse glycoprotein positive control, human 
albumin, GTKOp and human Fn.  (C) Coomassie stained gel and Neu5Gc blot 
for GTKOp serum, human serum, GTKOp kidney and liver lysates. 
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Figure 4-5. Cross-reactivity of immunoaffinity-purified human IgG on a GTKOp 
Fn column (hIgG-GTKOp Fn).  (A) Coomassie stained gel and hIgG-GTKOp Fn 
immunoblot of E. coli lysate, human albumin, GTKOp and human Fn.  (B) 
Coomassie stained gel, total human IgG and hIgG-GTKOp Fn immunoblots of E. 
coli lysate, human albumin, GTKOp kidney and liver lysates. One high molecular 
weight cross-reactive band was identified across the gel and immunoblot (black 
arrow).  (C) List of proteins identified in the cross-reactive high molecular weight 
band.  * Molecular Weight Search (MOWSE) Scores > 36 indicate identity or 
extensive homology (p<0.05).  (D) Comparison of total human IgG and hIgG-
GTKOp Fn for sample IgG (mg/mL), anti-Neu5Gc IgG (ng/mL) (n=1, error bars = 
SE) and a normalized relative anti-Neu5Gc IgG concentration (n=1, error bars = 
SE). 
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Chapter 5: Discussion 
 
Discussion Objectives 
Our research has shed light on physiologic and immunologic barriers to 
clinical xenotransplantation more specifically xenotransplant-related 
thrombocytopenia and antibody-mediated rejection respectively.  Although a 
distinction is made between physiologic and immunologic obstacles, 
xenotransplant-related thrombocytopenia and antibody-mediated rejection 
appear interdependent upon further inspection.  Genetic modifications of pigs to 
improve antibody-mediated rejection may affect xenotransplant-related 
thrombocytopenia and vice versa resulting in many upcoming challenges in the 
field.  This chapter will summarize our research, comment on additional findings 
and thoughts, and discuss future directions and the relationship between 
physiologic and immunologic incompatibilities related to clinical 
xenotransplantation.  
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Xenotransplant-Related Thrombocytopenia 
Since no current therapies exist to treat life threatening acute on chronic 
liver failure, porcine liver xenotransplantation as a bridge to allotransplantation 
was proposed as a solution (1).  Xenotransplant-related thrombocytopenia and 
resulting hemorrhage was determined to be a major barrier (2).  Ex-vivo porcine 
liver perfusion experiments implicated liver sinusoidal endothelial cells (LSEC) 
and Kupffer cells (KC) to be involved with clearance of human platelets (3).  
Since cold storage of platelets cause rapid clearance after transfusion, 
associated mechanisms were evaluated for relevance in xenotransplant-related 
thrombocytopenia.  Receptors implicated in cold stored platelet clearance 
included CD11b / CD18 (Mac-1, CR3, αMβ2) and asialoglycoprotein receptor 1 
(ASGR1) (4, 5). 
Porcine KC and human platelet interactions were studied demonstrating 
human platelet clearance by porcine KC in vitro (Chapter 2).  CD18 receptor was 
targeted with antibodies and siRNAs and determined to be an important receptor 
for platelet clearance by porcine KC (Chapter 2) and recently the involvement of 
CD11b / CD18 receptor was identified in porcine liver sinusoidal endothelial cells 
(LSEC) (6).  Platelet clearance by KC could not be completely blocked through 
inhibition of the CD18 receptor implying redundant mechanisms.  Studies in 
porcine liver sinusoidal endothelial cells (LSEC) have determined 
asialoglycoprotein receptor 1 (ASGR1) to be involved with platelet clearance (7).  
Similar to CD18, inhibition of ASGR1 through antibody blocking and siRNAs led 
to reduction in human platelet uptake by porcine LSEC.  KC have been shown to 
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express the ASGR1 receptor by others (8) representing another area of further 
investigation. 
Platelet surface carbohydrates exposed from loss of sialic acids from 
platelet membrane glycoproteins have been implicated in the platelet clearance 
(4).  The heterodimer CD11b / CD18 and ASGR1 are pattern recognition 
receptors. Mac-1 and ASGR1 recognize carbohydrates through carbohydrate 
binding domains, which are lectin-like (9) and C-type lectin domains (10) 
respectively.  Mac-1 has a broad range of carbohydrate recognition including 
glucose derivatives, mannose and β-glucans, for example galactose β1-4 N-
acetyl glucosamine (Galβ) and N-acetyl glucosamine β1-4 N-acetyl glucosamine 
(βGlcNAc) (9, 11).  ASGR1 has affinity towards β-glucans with terminal galactose 
such as Galβ (10).  Differences in human and pig carbohydrate binding domains 
for Mac-1 and ASGR1 were identified (chapter 3) which may alter affinities for 
carbohydrate substrates resulting in cross species incompatibility.  Comparison 
of human and pig platelet surface β-glucans demonstrated higher amounts of 
Galβ and βGlcNAc on human platelet surface before and after removal of sialic 
acids (chapter 3).  Receptor differences and larger amount of β-glucans on 
human platelets implicate possible aberrant recognition of human platelets by 
porcine Mac-1 and ASGR1 receptors.  Knockout, diminished expression or 
humanizing the carbohydrate domains of porcine Mac-1 and ASGR1 receptors 
may result in attenuation of xenotransplant-related thrombocytopenia. 
Many questions remain regarding the mechanisms of human platelet 
clearance by porcine sinusoidal cells summarized in Figure 5-1.  Our lab has 
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demonstrated pig LSEC and KC are capable of human platelet phagocytosis in 
vitro, however other sinusoidal cells may be involved directly or indirectly with 
this process including hepatocytes and stellate cells.  Further, incomplete 
inhibition of human platelet phagocytosis by pig KC through inhibition of the 
CD18 receptor indicates that our understanding of the mechanisms for pig KC 
phagocytosis of human platelets is not comprehensive. 
Apart from the incomplete understanding of the mechanisms behind 
xenotransplant-related thrombocytopenia, many concerns exist for generating 
pigs with altered CD18 and ASGR1.  The knockout of the CD18 receptor was 
successful in mice (12), however the leukocyte adhesion deficiency disease 1 in 
humans with complete lack of CD18 often results in patient death within one year 
(13) questioning viability of a CD18 knockout pig.  Although changes to 
carbohydrate binding domains of porcine Mac-1 and ASGR1 may be a viable 
alternative, incompatibilities may result in the demise of such genetically modified 
pigs.  In vitro experiments have demonstrated a reduction in human platelet 
uptake through inhibition of CD18 and ASGR1.  Whether or not such modification 
will result in clinical attenuation of xenotransplant-induced thrombocytopenia 
remains unknown.  Although generation of CD18 or ASGR1 modified pigs may 
provide insight to such questions, further in vitro evaluation appears necessary 
given incomplete attenuation of thrombocytopenia attained in our experiments. 
 
 
 
 139 
Future Directions for Xenotransplant-Related Thrombocytopenia 
  Since phagocytosis is a complex highly regulated process with 
involvement of many receptors, lack of complete inhibition of human platelet 
phagocytosis through inhibition of CD18 on porcine KC (chapter 2) was not 
surprising.  Phagocytosis may functionally be divided into two categories 
depending on the target engulfed. Invading pathogens and apoptotic cells (AC) 
must be engulfed to prevent infection and maintain cellular homeostasis 
respectively (14, 15).  Mac-1 functions as part of the innate immune system (16) 
and as a result, human platelets may be recognized as foreign and cleared by 
porcine KC.  ASGR1 is implicated in clearance of AC (15) and glycoproteins 
through recognition of carbohydrates following desialylation (17).  Human 
platelets may appear apoptotic to porcine phagocytes leading to recognition and 
clearance through ASGR1 expressing cells.  Since Mac-1 and ASGR1 are 
implicated in platelet and apoptotic cell clearance (18, 19), exploration of AC 
clearance mechanisms and its relation to xenotransplant-related 
thrombocytopenia appears warranted. 
Apoptotic cell phagocytosis process has been divided into several phases, 
which includes recognition, tethering, signaling and phagocytosis corresponding 
to initial interaction, binding, extra and intra-cellular communications and 
engulfment respectively (19).  CD11b / CD18 and ASGR1 belong to receptors 
responsible for signaling and tethering (19, 20).  Many receptors have been 
studied regarding each phase of apoptotic cell clearance and among these 
receptors, signal-regulatory protein alpha (Sirp-α, Src homology 2 domain-
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bearing protein tyrosine phosphatase substrate-1, SHPS-1) and CD31 (platelet-
endothelial cell adhesion molecule-1, PECAM-1), appear noteworthy for further 
evaluation for their implications in CD18 regulation in addition to AC 
phagocytosis (Figure 5-2) (19, 21-23).   
The interaction between macrophage SIRP-α and platelet CD47 was 
found to regulate platelet homeostasis through inhibition of platelet clearance 
(24).  Phagocyte SIRP-α mediates the tethering stage of AC phagocytosis by 
interaction with AC CD47 (25) and inhibits phagocytosis through immunoreceptor 
tyrosine-based inhibition motif (ITIM) signaling by negatively regulating CD11b / 
CD18 expression (22).  Xenotransplant studies have identified an incompatibility 
between SIRP-α on human macrophages and CD47 on porcine cells resulting in 
lack of downstream inhibitory signaling leading to clearance of porcine cells by 
human phagocytes (26, 27).  The reverse, compatibility of SIRP-α on porcine 
macrophages and CD47 on human platelets signaling to our knowledge has not 
been established in literature.  If porcine phagocyte SIRP-α and human platelet 
CD47 do not interact appropriately, inhibitory phagocytic signals would not be 
initiated possibly leading to human platelet phagocytosis justifying further 
evaluation (Figure 5-3). 
CD31 is described as part of the recognition phase of AC phagocytosis 
and has been demonstrated to upregulate several integrins including CD18 (β2 
integrin) expression in monocytes upon cell surface treatment with anti-CD31 
antibodies (21, 23, 28).  Homophilic interaction between CD31 on macrophages 
and AC has been implicated in initiating downstream stages of AC clearance (18, 
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28-31).  CD31 may disable phagocyte-AC detachment by inhibitory signals 
dependent on ITIM located in the cytoplasmic tail of CD31 (31).  Oligomerization 
of the CD31 receptors appear necessary to activate integrins (21).  Comparison 
of pig and human CD31 protein sequences using Basic Local Alignment Search 
Tool (BLAST) resulted in 71% maximum identity demonstrating substantial amino 
acid sequence differences.  A physiologic incompatibility between pig and human 
CD31 expressed on porcine KC, LSEC and human platelets may result in 
abnormal signaling resulting in the inhibition of platelet release and CD31 
oligomerization leading to integrin activation and human platelet phagocytosis. 
Since porcine CD18 inhibition resulted in attenuation of human platelet 
clearance by porcine KC (Chapter 2), additional investigation of receptors such 
as SIRP-α and CD31 with ability to regulate CD18 appears to be the next logical 
step.  Incompatibilities of inhibitory receptors, porcine SIRP-α / human CD47 and 
porcine CD31 / human CD31 may result in upregulation of CD18. ASGR1 
involvement in human platelet clearance demonstrated for porcine LSEC 
suggests redundant mechanisms involved.  Receptors involved with ASGR1 
regulation could be other potential targets for evaluation in xenotransplant-related 
thrombocytopenia. 
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Antibody-Mediated Rejection and Xenoantigens 
 Host antibodies recognizing antigens on transplanted grafts result in 
complement fixation and graft dysfunction known as antibody-mediated rejection 
as demonstrated in xenotransplant models (32-41).  When wild-type pig organs 
are transplanted into non-human primate models, graft rejection within minutes to 
hours occurs known as hyperacute rejection. Deletion of a major carbohydrate 
antigenic epitope, galactose α1,3-galactose (αGal), on wild-type pigs has 
significantly reduced the incidence of hyperacute rejection in pig to non-human 
primate xenotransplant models (34, 35, 37, 42).  Generation of pigs lacking αGal 
through knockout of the α1,3-galactosyltransferase  gene (GTKO) demonstrated 
ability to improve xenograft immune compability through genetic modifications of 
pigs.  The ensuing acute or delayed rejection due to other antigens continue to 
be an obstacle to overcome, since antibodies towards donor graft antigens have 
been attributed for hyperacute, acute and more recently chronic rejection (43, 
44).  This highlights the importance of host antibody and graft antigen interaction 
in transplant rejection.  Since human antibodies have been shown to recognize 
antigens and cause fixation of complement on pig cells lacking αGal (Chapter 3), 
antibodies reacting towards GTKO pig xenoantigens were further evaluated. 
 Porcine proteins, oligosaccharides, lipids, glycoproteins, glycolipids, DNA, 
RNA and other biological materials recognized by host antibodies are 
xenoantigens.  Specific sites on porcine biological materials that are bound by 
human antibodies are xenoantigenic epitopes.  For example, αGal was 
determined to be an antigenic epitope on porcine glycoproteins (45).  Rejection 
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studies involving GTKO pig organs in non-human primates suggest evidence of 
acute vascular type of rejection (35, 46, 47).  Human antibodies recognized 
GTKO porcine endothelial cells that line vasculature resulting in complement 
fixation and decreased cell viability (Chapter 4).  Evaluation and identification of 
xenoantigenic epitopes on the endothelial cell surface appears most relevant to 
improving xenograft compatibility. Since many cell surface proteins are 
glycosylated and antigenic epitopes may be peptides or oligosaccharides, 
antigenic porcine glycoproteins expressed on the cell surface of the endothelium 
would be ideal for study.  GTKO fibronectin (Fn) glycoprotein was chosen for 
evaluation, because of abundant expression on pig endothelial cells (Chapter 4) 
and induction of antibodies in pig to non-human primate cardiac xenotransplant 
studies (42).   
 Confirming the existence of preformed human antibody towards GTKO Fn 
was much more difficult than initially anticipated. Determining appropriate 
negative control conditions required alterations to many commonly used 
protocols in proteomic studies due to existence of preformed human antibodies 
towards denatured, unfolded or misfolded human Fn.  This phenomenon could 
be explained by exposure of antigenic epitopes previously hidden when Fn 
unfolds allowing recognition by preformed human antibodies (48).  Although 
reasons for the presence of these antibodies remains largely unknown, a 
possible functional explanation could be a clearance mechanism for misfolded or 
damaged Fn in plasma similar to damage associated molecular pattern 
hypothesis of preformed human antibody recognition of damaged cells (49).   
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Anecdotally, human antibody recognition of human endothelial cells was noted 
on several occasions when cells used were overgrown in cell culture dishes. 
Regardless, presence of such antibodies has lead to stringent protein 
preparation conditions.  Purification of Fn for antigen evaluation required an 
affinity column and size exclusion column followed by urea refolding process to 
attain native conformation Fn.  Denaturing agents such as strong detergents and 
reducing agents such as 2-Mercaptoethanol frequently used to increase 
resolution in electrophoresis was avoided to prevent erroneous results leading to 
confirmation of greater preformed human antibody recognition of GTKO Fn 
relative to human Fn. 
 Carbohydrate evaluation demonstrated the presence of the N-
glycolylneuraminic acid (Neu5Gc), non-human sialic acid, on GTKO Fn (Chapter 
4).  Normal human serum antibodies toward Neu5Gc have been shown (50) and 
several studies have identified Neu5Gc as an antigenic determinant capable of 
initiating complement dependent cytotoxicity (51-53).  When human IgG was 
purified against GTKO Fn, presence of anti-Neu5Gc IgG was detected confirming 
Neu5Gc as an antigenic epitope on GTKO Fn (Chapter 4).  The amount of 
human anti-Neu5Gc IgG was relatively small compared to the total amount of 
human anti-GTKO Fn IgG purified on a GTKO Fn column suggesting the 
presence of other antigenic epitopes on GTKO Fn.  Although several other 
potential antigenic proteins were identified using human anti-GTKO Fn IgG, 
possible cross reactivity of the anti-Neu5Gc antibodies to Neu5Gc on identified 
proteins complicates the end results.  In order to more conclusively identify 
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presence of further antigenic epitopes of GTKO Fn, sialic acids were removed 
using Sialidase A.  Unfortunately, removal of sialic acids from human Fn negative 
control resulted in positive human antibody recognition on western blotting.  The 
findings were not surprising given that glycosylations have a role in protein 
folding resulting in aforementioned issues (54).  Similar to the pre-GTKO pig era 
and studies evaluating non-αGal antigens, definitive evidence for non-Neu5Gc 
antigens was difficult to confirm experimentally using Neu5Gc positive pigs. 
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Future Directions for Antibody-mediated Rejection and Xenoantigens 
 
 Although our GTKO Fn studies suggest other antigenic epitopes present 
other than Neu5Gc, knockout of the Neu5Gc antigen in addition to αGal appear 
necessary to conclusively determine clinical relevance of Neu5Gc and identify 
non-Neu5Gc antigenic epitopes.  Recently, generation of pigs lacking αGal and 
Neu5Gc was accomplished in our lab.  Zinc finger nucleases were used to 
knockout α-1,3 galactosyltransferase gene responsible for the αGal antigen 
followed by knockout of cytidine monophosphate-N-acetylneuraminic acid 
hydroxylase (CMAH) gene required for the conversion of N-acetylneuraminic acid 
(Neu5Ac) to Neu5Gc (Figure 5-4) (55).  Somatic nuclear cell transfer was used to 
generate GTKO pigs then GTKO/CMAHKO pigs (Figure 5-5) (55).  The 
phenotypes of these pigs were confirmed through flow cytometry and confocal 
analysis (Figure 5-6) (55). Evaluation of GTKO/CMAHKO peripheral blood 
mononuclear cells (PBMC) demonstrated decreased recognition by preformed 
human antibodies and reduced complement dependent cytotoxicity compared to 
GTKO PBMC (Figure 5-7) (55).    
Initial evaluation comparing antibody binding and complement dependent 
cytotoxicity between human and baboon, chimpanzee, GTKO/CMAHKO pigs 
demonstrated similar levels of cytotoxicity (Figure 5-8).  Concordant xenograft 
transplantation such as chimpanzee to human renal transplantion (Reetsma et 
al) has previously shown some promise in clinical studies even without modern 
immunosupression drugs (Chapter 1), suggesting possible clinical success with 
the comparable GTKO/CMAHKO pig renal xenografts. Although the generation 
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of GTKO/CMAHKO pigs appears to be a significant advancement in pig to 
human immune compatibility, there continues to be antibody recognition and 
cytotoxicity of GTKO/CMAHKO pig cells compared to human control. Further 
evaluation of xenoantigens in the absence of Neu5Gc is necessary to reach 
allotransplant level of immune compatibility.  Continued evaluation of fibronectin 
from GTKO/CMAHKO pigs may allow identification of other significant antigenic 
epitopes for removal. 
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Concluding Remarks 
Utilization of life saving organ transplantation and treatment of critical 
illnesses involving organ failure continue to be limited by the shortage of donor 
organs.  Clinical xenotransplantation could alleviate the donor organ shortage.  
Research in xenotransplant-related thrombocytopenia and immune 
incompatibility has not only improved my understanding of the mechanisms 
behind these barriers, but has changed my overall thought process behind the 
barriers to xenotransplantation. 
Physiologic and immunologic incompatibilities between humans and pigs 
appear to be intimately related scientific obstacles preventing successful clinical 
xenotransplantation.  For instance, differences in human and porcine cell surface 
receptors CD11b / CD18 were implicated in causing xenogeneic platelet 
clearance. Since CD11b / CD18 is a known pattern recognition receptor involved 
with the innate immune system (16), receptor differences between humans and 
pigs could affect intrinsic immune compatibility.  Genetic modifications such as 
knockout or humanization of porcine receptors to improve physiologic 
compatibility may dually lead to a reduction in xenoantigens diminishing 
antibody-mediated rejection.  
Immune incompatibility may also affect physiologic incompatibility.  The 
ability of antibodies to block the function of cell surface receptors has been 
commonly used in scientific experiments.  For example, mouse anti-CD18 
antibodies were used to block the function of the receptor in porcine Kupffer cells 
resulting in human platelet phagocytosis (Chapter 2).  Similarly, human 
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antibodies that recognize porcine cell surface receptor antigens may alter 
receptor function resulting in physiologic dysfunction.  Modifications to pigs that 
reduce antigenic epitopes may improve in vivo physiologic compatibility.  
The creation of GTKO/CMAHKO pigs lead to humanization of porcine 
sialic acids, Neu5Gc to Neu5Ac, found on many cell surface receptors.  Sialic 
acids have been implicated in numerous physiologic and immunologic functions 
that involve molecular and cellular interactions through the ability to block 
antigenic peptide epitopes, carbohydrate ligands and cell receptors and its 
capacity to act as a ligand especially for antibodies and mammalian lectins (56).  
The capability of sialic acids to block recognition of cells through masking of 
carbohydrate epitopes was demonstrated in chapter 3 when desialylation of 
platelets resulted in increased human platelet recognition and clearance by 
porcine cells.  Variation in sialic acid masking of GTKO pig and human Fn could 
be partially responsible for human antibody recognition of GTKO pig Fn, yet 
another area needing evaluation.  Blocking the function of receptors through 
sialylation has been demonstrated for the β1 integrin receptor preventing cell 
adhesion and silencing of the LYVE-1 receptor in lymphatic endothelium (57).  
Siglecs, which bind sialic acids, have ability to alter cell-to-cell interactions (56).  
Comparison of Siglec-2 between mice and humans has revealed affinity 
differences for Neu5Gc and Neu5Ac highlighting potential physiologic and 
immunologic changes in pigs lacking Neu5Gc (58).  Since sialic acid changes 
from Neu5Gc to Neu5Ac may affect receptor function, reevaluation of 
xenotransplant-related thrombocytopenia for GTKO/CMAHKO pigs is needed. 
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In conclusion, continued research is necessary for clinical 
xenotransplantation to become a reality given the complexities for bridging the 
physiologic and immunologic gaps between humans and pigs.  Recent advances 
in genetic engineering have allowed quicker generation of genetically modified 
pigs for human compatibility analysis enhancing xenotransplant research efforts.  
Resolution of xenotransplant-related thrombocytopenia and antibody-mediated 
rejection barriers will require further research and likely further genetic alterations 
to pigs in order to attain clinical success. 
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Figure 5-1.  Model of porcine liver sinusoidal endothelial cell (LSEC) and Kupffer 
cell (KC) clearance of human platelets.  Porcine LSEC shown on the left 
expresses asialoglycoprotein receptor 1 (ASGR1) with affinity towards exposed 
galactose linked to N-acetylglucosamine (GlcNac).  Porcine KC shown on the 
right expresses CD11b / CD18 with affinity mainly towards exposed GlcNac.  Pig 
platelet on the left with fewer exposed galactose and GlcNac comparted to the 
human platelet on right.  Pig platelets express N-acetylneuraminic acid (Neu5Ac) 
and N-glycolylneuraminic acid (Neu5Gc).  Human platelets express Neu5Ac. 
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Figure 5-2.  Receptors implicated in apoptotic cell clearance by macrophages 
adapted from Gregory 2004 (19). Receptor abbreviations: β2 integrin, 
CD11b/CD18; ASGPR, asialoglycoprotein receptor (ASGR1/2); SHPS-1, Src 
homology 2 domain-bearing protein tyrosine phosphatase substrate-1 (signal-
regulatory protein-alpha, Sirp-α); dCD31, disabled CD31 (platelet-endothelial cell 
adhesion molecule-1, PECAM-1); 2GPI-R, 2-glycoprotein I receptor; ABCA1, 
ATP-binding cassette transporter 1; Altered CHO, altered carbohydrate; BAI-1, 
brain-specific angiogenesis inhibitor 1; CRT, calreticulin; MFG, milk-fat globule 
EGF-8; OxLls, oxidized LDL-like site; OxPL, oxidized phospho- lipid;  TBS, TSP-
binding site; Tim 1,3,4, T cell Ig and mucin domain-containing molecule 1, 3, or 4.  
CD31 and Sirp-α have regulatory roles for CD18 when interacting with apoptotic 
cells. 
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Figure 5-3. Diagram representation of porcine Sirp-α interaction with human 
CD47 from Leela Paris Ph.D 2013.  Porcine CD47 (pCD47) interacts 
appropriately with porcine signal-regulatory protein-alpha (pSirp-α) resulting in 
phoshphorylation of the immunoreceptor tyrosine-based inhibitory motif recruiting 
SH2 tyrosine-specific protein phosphatase (SHP-2) inactivating the phagocytosis 
signal. Interaction between human CD47 (hCD47) and pSirp-α may not result in 
active SHP-2 resulting in continued phagocytosis signal. 
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Figure 5-4. Diagram description of cytidine monophosphate-N-acetylneuraminic 
acid hydroxylase (CMAH) function and result after knockout of the CMAH gene in 
α1,3 galactosyltransferase knockout (GTKO) pig background.  GTKO pig cells 
express the CMAH enzyme necessary to catalyze the conversion of CMP-N-
acetylneuraminic acid (CMP-Neu5Ac) to CMP-N-glycolylneuraminic acid (CMP-
Neu5Gc).  Knockout of CMAH results in inability to convert CMP-Neu5Ac to 
CMP-Neu5Gc resulting in cell surface expression of N-acetylneuraminic acid 
(Neu5Ac) and not N-glycolylneuraminic acid (Neu5Gc). 
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Figure 5-5.  Photo of α1,3 galactosyltransferase and cytidine monophosphate-N-
acetylneuraminic acid hydroxylase double knockout pigs at 1 week old. 
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Figure 5-6.  Confocal microscopy comparison of domestic, α1,3 galactosyl-
transferase knockout (GTKO) and GTKO / cytidine monophosphate-N-
acetylneuraminic acid hydroxylase double knockout (GTKO/CMAHKO) pigs 
modified from Lutz 2012 (55).  Galactose α1,3 galactose epitope evaluated using 
Isolectin B4 staining.  N-glycolylneuraminic acid was evaluated using chicken 
anti-N-glycolylneuraminic acid IgY. 
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Figure 5-7.  Human IgM, IgG antibody recognition and cytotoxicity analysis of 
peripheral blood mononuclear cells (PBMC) comparing α1,3 galactosyl-
transferase knockout (GTKO) and GTKO / cytidine monophosphate-N-
acetylneuraminic acid hydroxylase knockout (GTKO/CMAHKO) pigs Lutz 2012 
(55).  (A) Ten subjects were evaluated using flow cytometer with random 
representative histogram (left). Mean fluorescence intensities of IgM and IgG 
compared in the bar graphs (right).  (B) Cytotoxicity compared by flow cytometer 
using fluorescein diacetate and propidium iodide staining.  Random subject was 
chosen for graph of % cytotoxicity per concentration of serum (left) and bar graph 
comparison of cytotoxicity at 2% serum of ten subjects (right). 
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Figure 5-8. Bar graph comparison of human serum IgM recognition, IgG 
recognition and % cytotoxicy of α1,3 galactosyl-transferase knockout pig 
(GTKO), GTKO / cytidine monophosphate-N-acetylneuraminic acid hydroxylase 
knockout pig (GTKO/CMAHKO), baboon, chimpanzee and human peripheral 
blood mononuclear cells (PBMC) provided by Andrew Lutz MD 2013.  
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